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SUMMARY 
 
The subject matter for this research work is the area of perioperative recovery for patients 
undergoing major abdominal surgery. During clinical studies we have investigated some 
of the factors influencing postoperative recovery as well as suggesting strategies to 
improve patient care. 
 
The main focus of the scientific work of this thesis is the role of intravenous fluids in the 
perioperative management of patients undergoing abdominal surgery. We found that 
restriction of intravenous fluid in the postoperative period does not significantly improve 
recovery in terms of gastrointestinal function (4.2 (3.2-6.9) versus 4.7 (3.7-6.1) days; 
p=0.80) or hospital stay (5.9 (4.0-7.9) versus 5.8 (4.1-7.3) days; p=0.90). Analysing our 
findings in the context of what is already known suggests that the immediate 
perioperative period when the effect of the metabolic-endocrine response is at its greatest 
is the most important period for fluid management. During this period fluid optimisation 
has an important role in patient recovery but following this period the body’s own 
homeostatic mechanisms are more able to cope with any fluid excess. We also found that 
using a ‘fast-track’ regime we could reduce hospital stay to levels comparable with other 
studies in the published literature.  
 
 Our work using a multi-modal rehabilitation regime in association with both 
laparoscopic and open surgery suggests that it is the postoperative care package which 
has the more major influence on recovery. Our findings are in agreement with other small 
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sized studies beginning to appear in the literature and indicate that further large scale 
studies are required to determine the role of laparoscopic surgery and any potential 
benefits. 
 
One of the most significant causes of morbidity for patients undergoing abdominal 
surgery is postoperative ileus. During the course of our studies we found that the extent 
of surgery and particularly handling and exposure of the intestines seems to have little 
effect on the duration of postoperative ileus. These findings add to the previously 
contradictory findings of other groups. 
 
Our experience with ‘fast-track’ postoperative programmes was also applied to liver 
surgery, an area where it has not previously been reported, to show that a variety of 
abdominal procedures may benefit from this approach. By comparing our results with 
series published in the medical literature we found that hospital stay can be significantly 
reduced (4 versus 5-8 days). 
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1.1 PERIOPERATIVE RECOVERY 
 
The development of modern surgery has focused on several different elements with the 
aim of improving overall outcome. One of the primary areas of interest has been the 
technical aspect of surgery which includes not only the precise methods for carrying out a 
procedure but also training and technological advances. For as long as the importance of 
technique has been recognised, clinicians have also been aware that the perioperative care 
of the patient has a significant influence on the overall outcome from surgery. In 
particular over the last decade there has been a sustained interest in the medical literature 
regarding both individual interventions and processes and pathways relating to recovery. 
 
The renewed interest in perioperative recovery has been driven by a number of different 
factors not least of these the increasing pressure on resources in healthcare systems 
struggling to meet the cost of new technology and the demand of an ageing population. 
Particularly in the United Kingdom with the restraints of a National Health Service 
funded through taxation, rising costs have led to reduced bed numbers, higher bed 
occupancy rates and drives toward cost-efficiency. An ageing population has only added 
to these challenges as excellence in the face of significant co-morbidity has come to be 
expected. The development of ‘day-surgery’ has been a timely answer to many of these 
problems. Borne out of the improvements already realised in perioperative care and in 
conjunction with shorter-acting anaesthetic agents, day-surgery has changed expectations 
with principles being applied to a growing number of procedures.  
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When discussing perioperative care a number of phases have to be taken into account. In 
the preoperative phase it is clear that preparation for theatre is an important aspect. Firstly 
the baseline state of the patient needs to be assessed and optimised which will include 
attention to co-morbid illnesses and also the effect their presenting condition may exert 
on nutrition and general wellbeing. With respect to abdominal surgery preoperative 
interventions such as bowel preparation, nutritional supplementation and fluid balance 
may all have a bearing on the postoperative outcome. In addition to these factors it is 
clear from the literature that the psychological preparation of the patient preoperatively 
can also have an effect postoperatively reducing pain and analgesic use1, 2.  
 
During the intraoperative phase both surgical and anaesthetic technique play a vital role. 
Through the work of early pioneers such as Sir David Cuthbertson we now understand 
that the response to injury, which includes the insult of surgery, involves activation of the 
hypothalamic-pituitary axis and autonomic nervous system with an overall catabolic 
effect3. It has therefore been postulated that intervention focused on reducing the stress of 
surgery may in turn reduce the inflammatory response and improve recovery. This has 
led to surgeons embracing the ideas of minimal access techniques with precise and 
limited dissection. Anaesthetic technique has also been influenced with studies examining 
analgesic regimes aimed at reducing perioperative pain and stress. Methods to block the 
afferent pathways involved in the metabolic-endocrine response have also been 
investigated. 
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Many of the interventions made in the intraoperative phase such as fluid management, 
analgesia and placement of monitoring devices will continue into the postoperative phase. 
During this phase management of the surgical patient can become even more complex as 
a number of different members of the multi-disciplinary team become involved. 
Furthermore the interventions made in this phase have been especially influenced by 
decades of surgical tradition rather than the principles of evidence-based practice. The 
use of surgical drains, nasogastric tubes and postoperative feeding regimes have until 
recently been guided purely by practice handed down through the apprenticeship model 
of training. Recently these traditions have been challenged and it is in these areas that 
some of the most significant advances in perioperative recovery have been made. 
 
Along with the increased knowledge base regarding individual interventions it is also 
clear that on their own their success in modifying the surgical stress response and end 
organ dysfunction is limited. From this realisation has come the idea of an integrated care 
pathway aiming to bring together evidence-based practice with a synergistic effect. A 
large proportion of the work in this area termed ‘fast-track surgery’ has come from 
Professor Henrik Kehlet’s group in Denmark. They suggest that by using a multimodal 
rehabilitation regime the stress response to surgery can be significantly reduced and along 
with this hospital stay and time taken to return to normal activities. They further highlight 
that the success of areas such as feeding and mobilisation is intimately linked to other 
parts of the regime such as a dynamic analgesic and antiemetic regime. By approaching 
the problem in this way they argue that the result may be more than just the sum of its 
parts. 
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Despite reports of initial success using a fast-track regime many clinicians have 
expressed concern that safety may be compromised. If patients are to be discharged 
sooner from hospital this may lead to patients developing significant complications at 
home and so delaying their presentation. Moreover the burden of health provision may 
simply be shifted from secondary care in hospital to primary care and general 
practitioners. In response to these concerns a number of groups have published their 
experience of fast-track surgery as well as refocusing their attention on the individual 
elements making up the multimodal programme. 
 
 
1.2 THE USE OF ASOGASTRIC TUBES I 
ABDOMIAL SURGERY 
 
Introduction 
The use of a nasogastric tubes is said to date back to 1790 when John Hunter stretched 
the skin of an eel over a whale bone to deliver enteral feeding to a patient with 
dysphagia4. The use of a tube to decompress the stomach was described much later in 
1884 by Kussmaul and further by Levin in 1921 who designed a single lumen tube5, 6. 
The routine use of nasogastric tubes in abdominal surgery is widely attributed to 
Wangensteen following a number of experiments on patients with small bowel 
obstruction reported in 19327. Because of the perceived reduction in mortality attributable 
to the use of nasogastric tubes they became routine not only in bowel obstruction but in 
all abdominal procedures. 
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The prophylactic use of nasogastric tubes remained part of ‘standard practice’ in 
abdominal surgery for more than 50 years despite people questioning its routine use as 
early as the 1960s8, 9. Advocates of the practice believe that the use of a nasogastric tube 
reduces postoperative ileus and the resultant nausea, vomiting and abdominal bloating. 
Furthermore it has been suggested to reduce other postoperative complications such as 
aspiration, wound dehiscence and anastomotic leak. 
 
The proposed mechanism is that the nasogastric tube drains secretions and gas from the 
upper gastrointestinal tract and thereby relieves nausea and vomiting, abdominal bloating 
and reduces the duration of ileus; however there are a number of problems with this. In 
the presence of an intact pylorus the tube is only likely to drain the stomach and we know 
from clinical and manometric studies that contractile activity returns to the stomach 
within a few hours10. The last part of the gastrointestinal tract to recover from 
postoperative ileus is the large bowel which can take a number of days and this is likely 
to account for the majority of the abdominal distension10. We also know that the 
nasogastric tube will only ever drain a fraction of the 8.5L estimated to be produced by 
the intestinal tract every 24 hours and so small bowel absorption must be present soon 
after the operation. It has also been previously theorized that the swallowing of air or 
aerophagia has a significant contribution to abdominal bloating and ileus and that the use 
of a nasogastric tube would avoid this, however nasogastric tubes themselves may 
promote aerophagia11, 12. 
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It is well recognized that nasogastric tubes cause a significant amount of discomfort for 
patients in the postoperative period and so many have looked again at the evidence with 
multiple randomised and non-randomised trials as well as reviews and editorials 
suggesting that routine nasogastric decompression is unnecessary after elective 
abdominal surgery8, 12-28.  
 
The evidence 
The evidence for the use of prophylactic decompression has been widely studied with 
particular attention paid to the difference between certain abdominal procedures. In 
colorectal surgery one of the largest prospective randomised trials was by Wolff et al. 
from the Mayo Clinic and published in the Annals of Surgery21. The study included 535 
patients undergoing elective colorectal surgery and found that there was no difference in 
hospital stay, pulmonary or wound complications between the group who were 
decompressed and the group who were not. They did note that there was an increase in 
abdominal distension, nausea and vomiting in the group who were not decompressed 
which amounted to around 10%. Moreover, 13% of this group required subsequent re-
insertion of the tube compared with 5% in the other group. Despite this increase in minor 
complications the authors concluded that ‘routine nasogastric decompression is not 
warranted after elective colon and rectal surgery’. 
 
Further evidence has been produced in upper gastrointestinal surgery where the use of 
nasogastric tubes has been uniform owing to the higher incidence of anastomotic leakage 
with proximal anastomoses. Furthermore truncal vagotomy and skeletonisation of the 
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coeliac plexus is thought to interfere significantly with upper gastrointestinal motility. A 
study looking at 136 patients undergoing radical (D2) gastrectomy for malignancy found 
that patients in the no decompression group had a reduced time to first flatus, time to 
liquid diet and hospital stay24. There was also no difference in fever, atelectasis, 
anastomotic leak rate or postoperative complications. 2 (3%) patients in each group 
required further insertion of a nasogastric tube. Another study looked at patients (n=66) 
undergoing total gastrectomy with oesophago-jejunal anastomosis and found that there 
was less sore throat, nausea, fever and pulmonary complications in the group without 
nasogastric decompression25. Finally in the largest series published of patients 
undergoing Roux-enY gastric bypass for obesity without nasogastric decompression 
(n=1015) the authors from UCLA report an anastomotic leak rate of 1% which suggests 
that the practice is safe29. 
 
As well as numerous studies looking at the use of nasogastric tubes following 
gastrointestinal surgery data is also available regarding its use in both Vascular and 
Gynaecological surgery. An American study looking at 80 patients undergoing elective 
abdominal aortic aneurysm surgery found no difference in postoperative outcomes with 
or without the use of nasogastric decompression30. They also reported that only 3 patients 
(7%) in each group required intubation in the postoperative period. A further study of 
patients undergoing gynaecological surgery for malignancy found patients experienced 
less pain and a quicker return of bowel function in the group without nasogastric 
decompression and no difference in any other complications31. 
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Criticisms of previous randomised and non-randomised trials published on the 
prophylactic use of nasogastric tubes have mainly focused on the number of patients 
involved in these trials especially when comparing rates of low incidence complications 
such as anastomotic leakage. Perhaps the most compelling evidence on the use of 
nasogastric tubes comes from two meta-analyses that have been carried out. The first of 
these was published in 1995 in the Annals of Surgery by Cheatham et al32. They included 
26 trials with a total of 3,964 patients undergoing a variety of abdominal procedures and 
looked at the main postoperative outcomes. They found that patients without routine 
nasogastric decompression had fewer episodes of postoperative fever, atelectasis and 
pneumonia and faster return to oral intake. There was an increased rate of abdominal 
bloating and vomiting but no overall increase in complications and the authors concluded 
that for every 1 patient requiring a nasogastric tube for postoperative nausea and vomiting 
20 patients could be spared the discomfort. This showed that routine use of nasogastric 
tubes was not required and that a policy of selective use for patients who develop 
symptoms does not prolong hospital stay or increase complications. 
 
The meta-analysis by Cheatham et al. was updated in 2005 by Nelson et al. and published 
in the British Journal of Surgery33. Since the first meta-analysis in 1995 a number of 
randomised trials had been published and the updated meta-analysis included almost 
double the number of randomised-controlled trials of the original. Furthermore in contrast 
to the original analysis no non-randomised trials were included. This analysis included 28 
trials and 4194 patients. It found an earlier return of bowel function in the group without 
tubes with a reduced rate of pulmonary complications approaching statistical 
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significance. There were no differences seen in the rates of ventral hernia however only 
one study reported this endpoint and there were no differences seen in anastomotic leak 
rate. More discomfort was found with the routine use of the tube. 
 
Conclusion 
Over the last 20 years the routine use of nasogastric decompression in elective abdominal 
surgery has been challenged by a number of trials and at least 2 large meta-analyses. 
Despite this wealth of evidence the traditions of surgery are often deeply ingrained and in 
a U.K. survey of 259 general surgeons carried out in 1991 92% of surgeons still used 
nasogastric decompression after Polya gastrectomy, 72% after small bowel resection and 
49% after large bowel resection17. A similar survey carried out in 1994 of American 
Colon and Rectal surgeons revealed that only 30% were still using routine nasogastric 
decompression34. This may represent a difference between general and specialist 
colorectal surgeons or indeed the difference between British and North American 
surgeons or possibly that at last the evidence regarding the prophylactic use of 
nasogastric tubes is being recognized. 
 
It is clear from the literature that nasogastric tubes do not prevent any of the 
complications that their advocates propose. They may well increase respiratory 
complications and there is no doubt that they cause significant discomfort to the patient. 
Furthermore there is no evidence of any increase in postoperative complications when 
their routine use is avoided.  
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1.3 THE USE O ITRA-ABDOMIAL DRAIS I 
ABDOMIAL SURGERY 
 
The history of drains in medicine 
The use of drains in medicine dates back to the Hippocratic era when, in his writings, 
Hippocrates describes using a drain to release pus from an empyema of the chest. 
Prophylactic drainage of the peritoneal cavity was first described much later in the mid-
nineteenth century by Sims and for almost as long there has been debate over their use. 
Theodore Billroth35, one of the fathers of gastrointestinal surgery, was convinced that 
drains had saved the lives of many of his patients while others such as Von Ott36 and 
Delbert37 argued that drainage of the general abdominal cavity was impossible. Tait, a 
great antagonist of Lord Lister (himself an advocate of drains), for once agreed when he 
stated ‘when in doubt, drain!’38. 
 
By the early twentieth century Yates, a surgeon from Chicago, in his seminal paper on the 
effects of peritoneal drainage, wrote: ‘There is probably no detail in modern surgical 
pathology that deserves more thorough comprehension, that which is less definitely 
understood by the average teacher, practitioner, and student than the reaction of the 
peritoneum to drainage; nor is there another that so often savors as strongly of pioneer 
mysticism, if expressed opinions written or spoken, may be taken as criteria.’ In over 30 
experiments Yates concluded that drainage of the general peritoneal cavity was 
impossible due to early encapsulation of the drain and that the serous exudates from 
drains were caused by their own foreign body reaction39-41. 
 30
How do drains work? 
The use of drains in colorectal surgery has been proposed for a number of theoretical 
reasons. Those who advocate the use of drains argue that it allows drainage of serous 
fluid and haematoma at the operative site which is at risk of becoming infected, forming 
an abscess and causing disruption of the anastomosis. They would also suggest that a 
drain close to the anastomosis will give an early indication of leakage by draining pus or 
faeces and possibly limiting the severity of the leak. On the opposing side of the 
argument those against prophylactic drainage suggest that drains may impede the healing 
of anastomoses and do not give an early indication of anastomotic breakdown or 
ameliorate the clinical effect. 
 
The healing of colorectal anastomoses depends on a number of local factors including 
adequate blood supply, the absence of tension on the anastomosis and good surgical 
technique. The contribution to healing from a number of other local factors is a matter of 
some debate. For intra-peritoneal anastomoses it is thought that access to omentum, 
peritoneum and bowel serosa is important for healing as they may provide additional 
blood supply in the presence of ischaemia and seal some anastomotic defects42, 43.  The 
situation is thought to be different for anastomoses below the peritoneal reflection where 
the bowel is surrounded by a large dead space. This dead space fills postoperatively with 
sero-sanguineous fluid produced by the raw surfaces following dissection and the absence 
of peritoneum means that resorption of fluid is markedly reduced. It is thought that this 
collection of fluid which provides a rich culture medium for bacteria is at risk of 
becoming infected and leading to abscess formation and anastomotic breakdown. 
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Anastomoses in the pelvis are also much more likely to be formed under tension and are 
less accessible for the omentum. 
 
Experimental trials 
A number of experimental trials have been carried out on the use of prophylactic 
abdominal drains. Berliner performed studies on dogs and observed leaks in 11 out of 20 
where the drain was found interposed between anastomosis and omentum suggesting that 
the drain forms a physical barrier to the omentum44. Manz carried out similar experiments 
finding that after left sided colonic anastomosis 9 of 20 dogs with drains died compared 
with 0 of 15 dogs without drains45. Nora and colleagues found that 9 out of 10 
splenectomized dogs in which drains were placed developed obvious signs of infection 
compared with none of the dogs in the group without drains46. 
 
Crowson and Wilson carried out one of the most detailed experimental studies into the 
use of prophylactic drains after intra-peritoneal colonic anastomosis in dogs. They found 
that in the absence of a drain the peritoneum appeared capable of controlling bacteria but 
when a drain was added to the contaminated area of an anastomosis the incidence of 
sepsis was significantly increased. They noted that anastomotic burst pressure was 
doubled in the group without drains suggesting an inhibition to local healing caused by 
drains. They also observed that due to the marked inflammatory response to the drain the 
tract was almost completely obliterated. This meant that in 8 dogs abdominal wall 
abscesses were present which were unable to drain as the tract no longer communicated 
with the peritoneal cavity. Of the different drain types used they found that silastic drains 
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produced less foreign body reaction than latex or PVC47. Smith et al. also investigated the 
effect of different drain materials in rats and found that latex inhibited local healing and 
lead to a significantly higher anastomotic leak rate39.  
 
Randomised clinical trials 
A number of clinical trails have been published which have tried to answer the question 
of whether prophylactic abdominal drainage is beneficial for patients. All of these studies 
have suffered from a similar problem which is that the outcome measure of anastomotic 
dehiscence is so rare a very large sample size is required to prove that there is no 
difference between the groups. Previous researchers have calculated that with a baseline 
leak rate of 5%, ruling out a 20% relative risk reduction in leak rate with a 5% 
significance level and 80% power would require 1080 patients in each treatment arm48. 
Many studies to date also include patients with intra-peritoneal and extra-peritoneal 
anastomoses and patients who have had defunctioning stomas making interpretation 
difficult. 
 
Sehapayak published a retrospective analysis of 44 patients undergoing extra-peritoneal 
anastomosis with or without suction drainage and found an increased complication rate 
and hospital stay in the group without drainage49. Collins and Talbot published a similar 
series of 39 patients and it was suggested that suction drainage was a useful adjunct 
during low anterior resection50. 
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Allen-Mersch carried out a randomised study of 30 patients and using CT measured fluid 
collections in the pelvis on the seventh postoperative day. He showed that despite the 
presence of a functioning drain residual collections were still present in the pelvis and the 
addition of suction made no difference to the size of the collection. He also noted that the 
lower the anastomosis the larger the collection of fluid51. 
 
Galandiuk and Fazio investigated whether the addition of irrigation to suction drainage 
had any effect on local septic complications randomizing 200 patients to their study. 
They did not observe any effect from irrigation with regard to pelvic sepsis or hospital 
stay52. 
 
Some of the strongest evidence on the issue of prophylactic drainage comes from a meta-
analysis published in the Annals of Surgery in 1999 by Urbach and colleagues46. The 
analysis included 414 patients undergoing both intra-peritoneal and extra-peritoneal 
anastomoses. It concluded that prophylactic drainage of colonic and rectal anastomoses 
does not reduce the rate of adverse events including clinical leaks. The studies included in 
the meta-analysis also reveal some other interesting findings. One study showed that 
there was no difference in the size of fluid collections between patients with or without 
drains53. It is also clear from these studies that drains are unlikely to ameliorate the 
clinical effects of a leak as in only 1 of 20 patients with an anastomotic leak did pus or 
faeces pass through the drain54-56. 
Since the publication of this meta-analysis there have been 3 further studies which seem 
to concur with the results. Merad et al. in a study of 319 patients found that drains did not 
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reduce either the rate or severity of complications and that there was no difference 
between suction and non-suction drains57. In a series of 707 patients undergoing large 
bowel resection with intra-peritoneal anastomosis Alves found that on multivariate 
analysis abdominal drainage was significantly associated with a higher risk of 
anastomotic leakage58. Finally, Yeh and colleagues recently published a series of nearly 
1000 patients undergoing anterior resection. They found that prophylactic drainage was 
not associated with a reduced rate of anastomotic leakage after anterior resection. They 
showed that irrigation-suction sump drainage was associated with a higher rate of leak 
independent from other risk factors59. 
 
Conclusion 
The varied experimental and clinical trials looking at the question of abdominal drainage 
have revealed a number of important findings. Drains when placed in the peritoneal 
cavity become rapidly encapsulated making their use limited. Certain materials such as 
latex may have local inhibitory effects on healing increasing the chance of dehiscence 
although whether they act as a physical barrier to the body’s natural defences is unclear. 
The placing of drains for intra-peritoneal anastomoses appears to be contraindicated by 
current evidence although the case in extra-peritoneal anastomosis is less clear. Drains do 
not appear to reduce the size of pelvic fluid collections and may themselves produce 
serous exudates through a foreign body reaction. The addition of suction or irrigation to 
pelvic drains seems to make little difference. In summary, the current evidence does not 
support the view that drains have any effect on rates of anastomotic dehiscence or that 
drains control the clinical effect of a leak. 
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1.4 MECHAICAL BOWEL PREPARATIO FOR 
ABDOMIAL SURGERY 
 
Introduction 
In the early part of the 20th century mortality rates from surgery on the gastrointestinal 
tract were high at around 20% mainly due to septic complications. For as long as bowel 
surgery has been possible surgeons have been looking at ways of trying to sterilise the 
contents of the colon to try to reduce the risk of infective postoperative complications. It 
is not exactly clear when the use of bowel cleansing first began but it may well have been 
introduced by military surgeons during the Second World War. Following this in 1966 
Plumley described a new regimen and mechanical bowel preparation (MBP) became 
widely accepted in the early 1970s60. Its use was further cemented into surgical dogma by 
a retrospective study of the aetiology of disruption of intestinal anastomoses by Irvin and 
Goligher in 1973 suggesting that poor MBP led to increased anastomotic leak rates61. 
 
The theoretical advantages of MBP include decreased intra-luminal bacterial counts, 
avoiding hard faeces from physically disrupting anastomoses and improving bowel 
handling by emptying the colon. Although the use of MBP has been seen by most as a 
‘standard of care’ there is very little hard evidence to support its use with expert opinions 
and clinical experience making up the bulk of the evidence base. Furthermore despite the 
introduction of routine prophylactic antibiotics surgeons were still reluctant to review the 
role of MBP. Since its widespread introduction in the 1970s almost no studies were 
carried out into the efficacy over the next 20 years, but rather concentrated on different 
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preparations to empty the bowel62-65. It was not until Irving and Scrimgeour published a 
series in 1987 of 72 patients undergoing a wide range of elective and emergency 
colorectal procedures without MBP and with low rates of infective complications (8.3% 
wound infection) that serious attention was given to the use of MBP66. This series was 
followed by a number of others all reporting excellent results without the use of MBP and 
so in 1992 Brownson published the first large randomised controlled trial on the use of 
MBP in elective colorectal surgery67-69. 
 
Experimental data 
Experimental data regarding the use of MBP is largely contradictory70. The use of animal 
models to investigate bowel cleansing is made more difficult by the differences in 
bacterial flora composition between species and also brought about by differences in 
dietary intake71. 
 
Studies carried out on both animal and human models have found that the use of MBP 
only reduces the total faecal mass but does not reduce the concentration of faecal micro-
organisms and so the concept of sterilising the bowel is misleading. Some authors have 
found that far from reducing the microbial counts, within 12-18 hours the concentrations 
are actually higher than pre-treatment levels71-73. 
 
A further study of 36 dogs undergoing low anterior resection, an operation with a higher 
rate of anastomotic dehiscence, found that in the group without MBP anastomotic 
bursting pressures were lower when compared with MBP (150mmHg vs. 250mmHg)74. 
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However in manometric studies of human colon in the postoperative period the maximum 
pressures reached across the anastomosis were around 45mmHg and so intra-luminal 
pressure seems unlikely to be implicated in the aetiology of anastomotic breakdown75. 
 
Trial evidence 
Through clinical experience many surgeons are aware that MBP can be poorly tolerated 
by the patient. In a questionnaire study of 58 patients by Solla et al. 88% found the 
procedure distressing to some degree and 41% complained of nausea, vomiting and/ or 
abdominal pain76. 10 patients stopped taking their preparation due to discomfort and 34% 
were still passing faecal fluid at the end of the procedure. This survey highlights very 
nicely the practical problems encountered with bowel cleansing not to mention the 
burden on nursing staff. For this reason alone the omission of MBP if it were safe would 
likely be welcomed by patients and clinicians alike. 
 
Aside from the patient’s experience of bowel preparation studies have looked at the other 
complications involved with the procedure. A number of studies have shown that MBP 
can cause significant electrolyte abnormalities, in particular reductions in serum calcium 
and potassium with a rise in serum urea77-79. While these changes are small and probably 
not significant for healthy individuals they may have important implications for a more 
elderly population such as those undergoing colorectal resection. MBP also causes 
significant weight loss of up to 1.2kg and postural changes in blood pressure due to 
dehydration and typically requires between 2-3L of fluid to compensate for the effect79. 
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One study also showed a reduction in exercise tolerance by 9% following the use of 
MBP78. 
 
As mentioned previously the first large randomised controlled trial to investigate the 
effect of MBP was by Brownson published in the British Journal of Surgery in 199269. 
They looked at 179 patients undergoing colorectal resection with or without MBP and 
found a higher leak rate in the group who received MBP with no difference in wound 
infection rates. In 1994 a study by Santos et al. of 149 patients found an increase in 
wound infection rates in patients having MBP (24 vs. 12%, p<0.05)80. However 
complication rates in this study were high and the authors themselves suggest this may be 
due to the experience of the surgeon carrying out the procedures. Another study in the 
same year by Burke et al. of 186 patients found no difference in outcomes between the 
two groups81. 
 
Since these first trials were published several similar studies have been reported in the 
world literature. A study by Zmora et al. of 380 patients found no differences in infective 
complications82. They also reported that postoperative diarrhoea was more common in 
the MBP group (7% vs. 0.5%, p<0.001). Spillage of bowel content was more common as 
was the presence of liquid faeces with fluid or semi-solid content reported in over 50%. 
Studies by Miettinen et al.83, Fa-Si-Oen et al.84 and Ram et al.85 have all failed to show 
any significant difference in outcome measures between groups with or without MBP. A 
recent study by Bucher et al. published in the British Journal of Surgery and looking only 
at patients having left sided colorectal resections (n=153) found an increase in infective 
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complications (22% vs. 8%, p=0.028) and in anastomotic leak (6% vs. 1%, p=0.021) with 
the use of MBP86. This translated to an increase in hospital stay (15 vs. 10 days, p=0.024) 
which was also significant for those patients not experiencing complications. In one of 
the largest trials of its kind Contant et al. carried out a multicentre randomised trial of 
1431 patients with no difference seen between groups in anastomotic leak rate (4.8% with 
MBP versus 5.4% without)289. 
 
One of the difficulties with trying to prove a negative effect particularly when the 
incidence of complications is low (<3% anastomotic leakage) is that very large numbers 
of patients are required for adequate power. This is difficult to achieve even in a multi-
centre setting without introducing further problems such as inter-operator variability. For 
this reason some of the best data is derived from meta-analyses and there have been 
several carried out on the subject of MBP. Bucher et al. first published their analysis in a 
Swiss medical journal, updating it for publication in the Archives of Surgery in 200487, 88. 
This included 7 RCTs and 1297 patients and found a significant increase in anastomotic 
dehiscence in the MBP group (5.2% vs. 2.8%, p=0.03). They did not find a difference in 
any other outcome measures. Wille-Jorgenson et al. also produced a meta-analysis for a 
Cochrane review in 2005 which was further published in Colorectal Disease89, 90. 
Looking at 9 RCTs with 1592 patients it also showed a significant increase in 
anastomotic leak with the use of MBP (6% vs. 3.2%, p=0.003). In this analysis wound 
infection rates showed a trend towards significance in favour of no MBP (5.4% vs. 7.4%, 
p=0.07). There was no difference in mortality. 
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Conclusion 
In a survey of North American colorectal surgeons carried out in 1990, 100% of the 352 
respondents used some form of mechanical bowel preparation76. In the last decade 
however with growing evidence suggesting at the very least no significant benefit and 
possibly an increase in the rate of anastomotic dehiscence opinions are starting to change. 
In national guidelines published in 2003 the Scottish Intercollegiate Guideline Network 
concludes that ‘current evidence…does not support its routine use’91. With even more 
evidence having been published since the introduction of these guidelines it is now clear 
that the omission of MBP is safe and may even be beneficial to the patient. 
 
 
1.5 PROPHYLACTIC ATIBIOTICS 
 
Introduction 
Since the advent of colonic surgery in the 19th century the most significant cause of 
postoperative morbidity and mortality has been infective complications. Even before 
colonic resection was commonplace the infective potential of colonic content was well 
recognised. The resident bacterial flora of the colon consists of high concentrations of 
both aerobic and anaerobic organisms. This bacterial reservoir can become a potential 
source of infection once the normal mucous membrane barrier has been disturbed by 
surgery. Recognising this risk has led to surgeons investigating numerous strategies to try 
to reduce the rates of postoperative infective complications. 
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Prophylactic antibiotic use describes the practice of administering antibiotics before there 
is any evidence of contamination or infection. The primary aim of prophylactic antibiotic 
use is to reduce the incidence of postoperative infective complications, but to be adopted 
into routine clinical practice it must fulfil additional criteria. The benefits should 
outweigh the risks particularly relating to drug toxicity. The antibiotic used should be 
site-specific with antimicrobial coverage directed at the likely pathogenic organisms. This 
should not only increase the efficacy of the treatment but also reduce selective resistance. 
Furthermore the antibiotic should have the appropriate pharmacokinetic properties to 
allow it to be present in the tissues for the duration of the period of maximum risk. 
 
The first recorded use of antimicrobial prophylaxis in colorectal surgery was in 1939 by 
Garlock and Seley92. They reported 21 patients undergoing colonic resection with oral 
sulphonamides for prophylaxis with only one resultant wound infection. It was not until 
the 1960’s that the first randomised controlled trial was carried out to look at the efficacy 
of prophylactic antibiotics but in the following decades it has been a common theme 
throughout the surgical literature. Risk factors for postoperative infections are now well 
known with extremes of age, malnutrition, obesity, diabetes, malignancy and steroid use 
among the most common. It is known that mortality rates are 2-3 times higher for patients 
who develop surgical-site infections. Patients will also stay in hospital on average 1 week 
longer with an increase of 10-20% in the cost of hospitalisation93, 94. With such 
significant consequences of postoperative infective complications on patient recovery, the 
potential benefits of prophylaxis are substantial.  
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Efficacy 
Since the first randomised trials looking at the effects of antibiotic prophylaxis in surgery 
in the 1960s there have been numerous trials in the literature providing strong evidence. 
Research has been carried out not only on the efficacy of prophylaxis but also on 
different regimes of antibiotics, the timing, dosing and route of administration as well as 
the duration of the antibiotic course. 
 
In a trial of 400 patients undergoing gastrointestinal or biliary procedures patients were 
treated with either an intramuscular cephalosporin or placebo. Wound infection rates fell 
from 22% to 4% for gastric surgery, from 11% to 2% for biliary procedures and from 
16% to 6% for colorectal surgery95. A further study of 350 patients by Coppa and Eng 
concentrated particularly on colorectal surgery. They found that wound infection was 
directly related to the length of procedure and also that surgery below the peritoneal 
reflection carried a significantly higher risk than colonic procedures. They also found that 
prophylaxis with a combination of oral neomycin and erythromycin in combination with 
a cephalosporin significantly reduced wound infection rates96. 
 
In a review of all the best trials to look at antibiotic prophylaxis in colorectal surgery 
between 1965 and 1980 Baum et al. found that 22 of the 26 trials meeting the inclusion 
criteria showed a significant benefit with antibiotics compared to no treatment97, 98. 
Wound infection rates were reduced from 36% to 22% and mortality rates fell from 
11.2% to 4.5%. Following the results of the review the authors concluded that the 
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evidence for antibiotic prophylaxis was so strong that ‘no treatment’ controls were no 
longer ethical. 
 
More recently the evidence has been looked at again in a systematic review by Song and 
Glenny of studies carried out between 1984 and 1995. This looked at the efficacy of 
prophylactic antibiotics in colorectal surgery examined in 147 trials. The review found 
the overall rate of wound infection to be 11% with prophylaxis and confirmed the 
effectiveness of prophylaxis99. 
 
Timing 
With the efficacy of antibiotic prophylaxis well proven further trials have looked at the 
issue of timing of administration. In the study by Stone et al. 400 patients undergoing 
either gastrointestinal or biliary procedures were randomised to receiving intramuscular 
Cefuroxime, either 12 hours before operation, immediately before the procedure or after 
the procedure95. They found no great difference between the preoperative doses but that 
the postoperative doses showed no efficacy in comparison. 
 
These findings are supported by a large retrospective review which was reported in 1985 
in the Archives of Surgery100. In a review of 2847 patients undergoing a variety of 
operations classed as ‘clean’ or ‘clean-contaminated’ 1708 patients were found to have 
received prophylactic antibiotics within 2 hours of their procedure with a resultant wound 
infection rate of 0.6%. 282 patients received antibiotics less than 3 hours after their 
procedure with 1.4% developing wound infections (p=0.12). 488 patients received 
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antibiotics over 3 hours after their operation with an infection rate of 3.3% (p<0.0001) 
and 369 had antibiotics more than 3 hours before operation with 3.8% developing wound 
infections (p<0.0001). This clearly showed that the best time to receive prophylactic 
antibiotics is in the 2 hours before the operation. 
 
In a further retrospective study of 2651 patients undergoing surgery Silver et al. found 
that although up to 94% of patients received prophylactic antibiotics, 27-54% did not 
receive them at the right time (i.e. less than 2 hours prior to surgery)101. These results 
were mirrored in a later review of practice in 2005 by Bratzler et al. who found that out of 
2965 patients only 55% received antibiotics within 1 hour of surgery102. 
 
The timing of antibiotic administration was further highlighted as an important issue in a 
study by DiPiro et al. who compared regimes using Cefazolin and Cefoxitin103. By 
carrying out serial blood measurements as well as muscle biopsies they showed that of 
the two drugs Cefoxitin has a shorter elimination half-life with 90% being eliminated in 3 
hours. This highlights the need to know the pharmacodynamic properties of the 
antibiotics being used for prophylaxis as certain regimes may not provide cover for the 
duration of maximum risk to the tissues. Furthermore it has been shown that long 
operations using antibiotics with a short half-life leads to more postoperative infective 
complications and repeated dosing intra-operatively may be required96. 
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Duration 
Another area of debate regarding the use of prophylactic antibiotics has been the duration 
of administration and whether a single dose or multiple doses are more effective. In a 
study of 311 patients undergoing both elective and acute colorectal surgery a single dose 
regime of cefuroxime and metronidazole was compared with giving 3 doses with no 
difference found between the two104. Another trial published in the British Medical 
Journal looked at 943 patients undergoing elective colorectal surgery comparing the same 
antibiotic regimes. It also found no difference in wound infection rates (7.1% versus 
7.3%) or mortality rates (6.6% versus 5.5%) between a single dose and a triple dose 
regime105. It concluded that there are practical and financial advantages to the single dose 
regime. 
 
Since these trials were published a systematic review has been carried out to draw 
together all the available evidence106. This included 28 trials with a total of 9478 patients 
with no difference between single and multiple dose prophylaxis. There was also no 
difference in shorter or longer than 24 hour extended dosing. 
 
Regimen 
The exact regimen used for prophylaxis is an issue too wide to be addressed in the course 
of this short review. Trials to look at drug regimens have mainly been driven by 
commercial research. There are however clear broad principles. The antibiotics used 
should be site-specific to cover the likely pathogenic organisms. This means that there 
will be different regimes for different procedures. In general studies have shown that for 
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gastrointestinal procedures the combination of either a cephalosporin and metronidazole 
or gentamicin and metronidazole are of equivalent efficacy. There are a number of other 
regimes of comparable efficacy with a few notable regimes having been shown to be 
inadequate including metronidazole alone, oral neomycin and erythromycin alone, 
gentamicin alone and cefotaxime alone. It has also been shown that first generation 
cephalosporins have comparable efficacy to the newer generations99, 107. There is also no 
difference between oral and parenteral regimes108. 
 
Conclusion 
With a wealth of evidence to support its use prophylactic antibiotics are now a routine 
part of surgical practice and have been adopted into national guidelines for good 
practice91. Prophylaxis is particularly important in colorectal surgery where the risk of 
postoperative infective complications is high and the effect on patient recovery can be 
severe. Antibiotic prophylaxis should be administered immediately before induction of 
anaesthesia and a single dose regime offers the most practical and cost-effective method. 
The route of administration does not seem to be important. The exact regime used will 
vary and depend not only on pharmacodynamic and microbiological characteristics but 
also on the results of local infection control surveillance. The most commonly used 
regime remains the combination of a cephalosporin and metronidazole and other regimes 
while proving equivalent have not shown superior efficacy. 
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1.6 MIDLIE VERSUS TRASVERSE ICISIOS 
 
Introduction 
Currently the choice of abdominal incision used for major abdominal surgery is dictated 
primarily by the preference of the surgeon. The incision should allow ease of access to 
the structures of interest as well as being quick to perform and secure when closed. The 
effect of incision type on patient recovery and postoperative morbidity is another 
important aspect which has been studied to try to find the optimal incision. 
 
The main area of debate with regard to incision type is between transverse and vertical 
incisions. Because the fibres of the fascial layers of the abdominal wall run transversely, 
tension from suture closure of a transverse wound will be at 90 degrees to the fibres 
rather than pulling along the line of the fibres which some argue should lead to a more 
secure closure. Transverse incisions should also achieve a better cosmetic result as they 
are parallel with Langer’s lines of cleavage. Furthermore a vertical incision crosses more 
segmental nerves which may lead to a more painful wound. 
 
To try to find the optimal wound for abdominal surgery a number of studies have been 
undertaken. There are however methodological problems with the studies published to 
date. Many of the studies are retrospective which raises the problem of selection bias with 
surgeons likely to use transverse wounds only in the most favourable situations. The 
studies performed have also looked at patients undergoing a variety of procedures and so 
the heterogeneity of the studies means that it is problematic to try to generalise the results 
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for all abdominal surgery. The other problem has been blinding of both the patient and 
carers to the type of incision which is difficult to achieve for obvious reasons. This again 
introduces an area of possible bias. 
 
Pulmonary function 
One aspect which has been investigated is the effect of incision on postoperative 
respiratory function. We know that in the immediate postoperative period patients 
respiratory function in terms of vital capacity and forced expiratory volume in 1 second is 
reduced and that it recovers over the following few days. The effect of abdominal pain 
and the incision is that patients splint their abdominal wall to avoid pain and therefore 
their expiratory excursion is reduced. This can also lead to reduced clearance of 
respiratory secretions, atelectasis and even pneumonia. 
 
In a study of 13 patients with respiratory disease and 13 patients with ‘normal’ lungs 
Becquemin et al. found that, although there was no difference in normal patients with 
either a transverse or a midline wound, in patients with respiratory disease postoperative 
lung function was significantly improved in patients with a transverse wound109. A 
further study of 132 patients undergoing biliary surgery found that respiratory function 
was less depressed postoperatively in patients with a transverse incision although the 
differences were small110. These results were again confirmed in a study of 40 patients 
undergoing right hemicolectomy in a study by Lindgren et al111. Despite the differences 
between the two groups in terms of respiratory function studies have failed to show 
consistent differences in pulmonary complications such as pneumonia109-114
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with no differences in significant clinical endpoints it is difficult to know whether the 
changes in FVC and FEV1 are of any great importance. 
 
Pain 
One area where more robust conclusions can be drawn is that of postoperative pain. In a 
study of 60 patients undergoing cholecystectomy through either a midline or subcostal 
incision there was a significantly reduced usage of analgesics in the transverse group112. 
Halasz also found transverse wounds to cause less pain in a study of 100 patients having 
biliary surgery113. Studies have looked at the effect of the wound size on postoperative 
pain and in a study comparing 6cm subcostal wounds with 15cm wounds O’Dwyer et al. 
showed significantly reduced analgesic intake as well as hospital stay in the 6cm 
group115. 
 
Overall morbidity 
Despite the evidence of reduced depression of respiratory function and less pain with 
transverse abdominal wounds studies have not shown any difference in hospital stay or in 
terms of postoperative complications110-112, 114, 116. Publications relating to pulmonary and 
wound complications have been contradictory and a recent Cochrane review of the 
literature reports no significant differences between the two groups114. One review of the 
available literature published in 2001 by Grantcharov suggested that transverse wounds 
had a lower rate of wound dehiscence, both early and late, however the review includes a 
number of retrospective series with a very high possibility of selection bias117. In the 
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more recent Cochrane review no difference in terms of burst abdomen or incisional 
hernia was found when looking at prospective, randomised trials114. 
 
Conclusions 
The evidence available on the optimal incision for abdominal surgery suffers from poor 
methodological quality and contradictory results. What evidence is available suggests that 
while transverse wounds may be less painful there is no difference in hospital stay, 
respiratory or wound complications. There is also no evidence available relating to 
patient satisfaction or cosmetic outcome. 
 
 
 
1.7 THE ROLE OF BLADDER CATHETERIZATIO I 
COLORECTAL SURGERY 
 
Introduction 
 
Urethral catheterisation is commonly used in the perioperative period following 
abdominal surgery to monitor urine output and to avoid postoperative retention which can 
occur in between 10-60% of patients118, 119. Causes for urinary retention are multifactorial 
and include the effect of drugs, operative damage to pelvic autonomic nerves and 
possible loss of anatomical support for the bladder. Despite the well established role of 
urethral catheterisation there is very little evidence available concerning its effect on 
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patient recovery and postoperative morbidity. Complications related to the procedure 
include urinary tract infection, discomfort, urethral stricture and the need for re-
catheterisation if spontaneous voiding fails. To reduce postoperative morbidity studies 
have looked at alternative routes of bladder catheterisation and also at the duration for 
which it is required. 
 
Suprapubic catheterisation 
Kronberg et al. reported the first large series using suprapubic catheterisation routinely 
for colorectal patients120, 121. In a series of 399 patients they found that in 31 patients they 
failed to insert the catheter and in a further 19 a urethral catheter was placed subsequently 
for recurrent or persistent retention. The average length of suprapubic catheterisation was 
7 days. Having shown that suprapubic catheterisation was a viable alternative other 
groups have looked in closer detail to compare the morbidity related to each procedure. 
 
Catheter-related discomfort 
In a randomised trial of 137 patients undergoing rectal surgery by Perrin et al. 14% of 
patients with a suprapubic catheter experienced morbidity compared with 32% in the 
urethral group122. Most of the increased morbidity was accounted for by catheter-related 
discomfort (12% vs. 29%). These findings seem to confirm the findings of a previous 
randomised study by O’Kelly et al. of 57 patients which found that more patients with 
urethral catheters complained of catheter-related pain (13 vs. 2, p<0.01) and on more 
days (37 of 126 cf. 6 of 142, p<0.001) than in the suprapubic group123. 
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Urinary tract infection 
 Despite studies suggesting that discomfort is increased with urethral catheters the 
evidence regarding urinary tract sepsis, the most important morbidity, remains 
contentious. In the studies by both O’Kelly123 and Ratnaval et al.124 no difference in 
urinary sepsis was seen between the two methods. Perrin122 found that there was almost a 
twofold increase in significant bacteriuria in the urethral group however the clinical 
consequences of this remain unclear. A further study of 66 patients by Sethia et al. did 
show a significant difference with 16 out of 34 patients developing a urinary tract 
infection in the urethral group and 2 out of 32 in the suprapubic group (p<0.001)118. 
However the validity of this result is questionable due to the very high infection rate in 
the urethral catheterisation group. 
 
Duration of catheterisation 
The issue of urinary tract infection and duration of catheterisation was addressed in a 
study of 126 patients undergoing rectal resection with patients randomised to drainage for 
either 1 day or 5 days125. Benoist et al. found that with only 1 day of urethral 
catheterisation urinary retention increased from 10% to 25% but UTI reduced from 42% 
to 20%. It was also seen that the vast majority of the patients who went into retention 
were patients with low rectal cancers. A follow up to this study by Kehlet et al. found that 
in a series of 100 patients undergoing colectomy with epidurals in-situ only 9 patients 
needed re-catheterisation and 4 developed UTI with the urethral catheter removed 24 
hours after surgery119. These studies suggest that it is possible to remove the urinary 
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catheter much earlier than has traditionally been the case and by doing so significantly 
reduce the risk of urinary tract infection. 
 
Conclusion   
The evidence that exists relating to bladder drainage following abdominal surgery and its 
relationship to postoperative morbidity and recovery is fairly limited. The evidence that is 
available suggests that urethral catheters cause more discomfort for patients and may 
increase rates of urinary sepsis. While some would argue that suprapubic catheterisation 
offers a safe alternative the technique has not gained widespread acceptance. It is also 
possible that simply reducing the duration of urethral catheterisation is safe and can 
significantly reduce the rate of urinary tract infection which is the major post-procedural 
morbidity. 
 
 
1.8 UTRITIO AD ITS EFFECT O RECOVERY 
FROM SURGERY 
 
The importance of nutrition in surgical patients has been recognised for many years. It 
has been estimated that almost half of all surgical patients suffer from malnutrition which 
is compounded by surgery and the reduced intake of protein and energy126. Malnutrition 
is clearly associated with increased morbidity and mortality after major gastrointestinal 
surgery. Furthermore the catabolic response to surgery can lead to delayed wound 
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healing, fatigue, depression of the immune system and prolonged convalescence127. It has 
also been postulated that this catabolic response can lead to a compromise in gut barrier 
function and bacterial translocation due to increased intestinal permeability and mucosal 
atrophy128.  
 
The often dual effect of malnutrition and the response to surgery has led to a number of 
studies looking at the effect of nutrition on recovery. They have concentrated on two 
main areas: the role of supplementation in combating malnutrition; and the effect of 
postoperative feeding on short term recovery. 
 
Despite sustained interest in supplementation for patients undergoing gastrointestinal 
surgery there is little evidence to suggest a major clinical benefit except in a very select 
group. In a study of preoperative oral supplements for at least 7 days in 179 colectomy 
patients Smedley et al. found that although supplemented patients lost less weight there 
was no difference in major complications and no overall clinical benefit129.  
One of the largest studies carried out in the area of preoperative feeding was the Veterans 
Administration study which looked at the effect of preoperative parenteral nutrition in 
patients with GI malignancy undergoing elective colorectal resection. 395 malnourished 
patients were randomised in total however only those with severe malnutrition showed 
any benefit in terms of morbidity with parenteral nutrition lasting between 7-15 days130. 
A number of other studies have also failed to show significant benefit in favour of 
preoperative feeding and the few that suggested a positive difference have suffered from 
high complication rates in the control arm making the conclusions questionable131-136. 
 55
 
Perhaps more controversial is the area of postoperative feeding and when this should be 
introduced. Traditionally feeding has only started once ileus is deemed to have resolved. 
These restrictions on oral intake have been based primarily on clinical experience rather 
than any scientific evidence. The difficulty with such an approach is the assessment of 
ileus. We know from experimental studies that listening for the return of bowel sounds is 
merely an indication of migratory myoelectric complexes in the starved state and is not a 
good indicator of gastrointestinal function in the fed state137, 138. We also know that ileus 
lasts only a matter of hours in the stomach and small intestine with the rate limiting step 
being return of peristalsis in the left colon, taking between 2-4 days10, 139. This has led 
many to question whether patients should be fed early in an attempt to ameliorate the 
catabolic response and improve recovery. Moves toward early feeding have also been 
encouraged by the introduction of laparoscopic surgery and the pressures of early 
discharge. 
 
A large number of trials have attempted to look at the efficacy and safety of postoperative 
feeding. These have included a wide variety of feeding methods in a fairly heterogenous 
group of patients in terms of their nutritional status making comparison difficult. 
 
In a study of 105 patients undergoing abdominal surgery randomised to delayed 
(traditional) or self-directed feeding, patients given the choice commenced diet 
significantly earlier (3 vs. 5 days, p<0.001). No differences were seen in complications or 
overall hospital stay140. A further randomised trial by Feo et al. of 100 patients 
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undergoing colectomy also found no difference in outcomes or complications with 80% 
of those in the early group tolerating oral diet from day 1 postoperatively141. This 
proportion of patients who tolerate early re-introduction of diet is fairly constant in the 
literature at around 80%. In a randomised trial of 197 patients with upper GI malignancy 
by Heslin et al. it was evident that the symptoms associated with initiation of diet were 
the same for both groups and only the timing was different due to the difference in when 
the gut was challenged. This study also showed no difference in hospital stay, 
complications or mortality142. Finally a study by Reissman et al. of 161 patients 
undergoing colorectal procedures found that diet was tolerated earlier in the early feeding 
group although there were no differences in duration of ileus, complications or hospital 
stay and they concluded that early feeding is indeed safe143. 
 
In an attempt to draw together the available evidence Lewis et al. carried out a meta-
analysis of 11 randomised controlled trials including 837 patients undergoing 
gastrointestinal surgery144. They found a reduction in septic complications, particularly 
wound infections and a reduction in hospital stay of 1 day. They also found risk 
reductions for anastomotic dehiscence, pneumonia, abscess and mortality approaching 
statistical significance (p<0.10). A significant increase in postoperative vomiting was 
found in the early feeding group. They concluded that early feeding may be beneficial 
although there was no clear advantage.  
 
Further evidence of the safety of early feeding has come more recently with the 
incorporation of early feeding into ‘fast-track’ recovery regimes with no increase in 
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complication rates reported in the literature145-148. Therefore while it is certainly safe to 
feed patients early following colorectal surgery with the majority of patients tolerating it 
well it is not clear whether it has any overall advantage in terms of patient recovery. 
 
 
1.9 POSTOPERATIVE ILEUS 
 
Introduction 
Following surgery the gastrointestinal tract takes time to recover its coordinated 
propulsive activity. This delay in the functional recovery of the bowel is often referred to 
as postoperative ileus. Through experimental studies we know that the pace of recovery is 
different in different parts of the alimentary tract. The first to recover is the small bowel 
in only a matter of hours followed by the stomach within 12-24 hours and then finally the 
colon at between 3-5 days. In the colon the right side is the first to resume peristalsis with 
the left colon being the rate-limiting step10, 137. Ileus can often be prolonged past 3 days 
and this is often referred to separately as postoperative paralytic ileus although many see 
the conditions as a continuum rather than separate entities149. 
 
Ileus is a major cause of postoperative morbidity especially following colorectal surgery 
with which it is most commonly associated. The condition is characterised by abdominal 
pain, distension, absent bowel sounds and delayed defaecation and can lead to nausea and 
vomiting. The result of postoperative ileus can be a reluctance to mobilise, delay in the 
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institution of oral diet and ultimately prolongation of hospital stay and increased 
healthcare costs. 
 
The pathophysiology of ileus is multifactorial and contributing factors are still a matter 
for debate and ongoing research. Inhibitory reflex arcs with afferents from somatic, 
visceral and parietal fibres are thought to play a part. Important also in the reflex arc is 
the interplay between the sympathetic and parasympathetic nervous system as well as the 
intrinsic nervous system of the gastrointestinal tract. In 1899 Bayliss and Starling 
demonstrated the role of sympathetic activity in gastrointestinal function by ablating the 
splanchnic nerves of dogs and recording the improvement in bowel activity150. As well as 
the inhibitory reflexes inflammatory mediators are thought to play a role along with 
endogenous and exogenous opioids. 
 
This review will examine some of the factors thought to be important in relation to the 
duration of ileus. Some of these areas will be covered in greater detail in other chapters. 
Furthermore as a major rate-limiting step in postoperative recovery from colorectal 
surgery ileus will be a major focus of the experimental work contained in this thesis. 
 
Extent, site and duration of surgery 
Ileus was first described by Pal in 1890 when he reported a reduction in intestinal motility 
following surgery151. Since then studies have looked at many contributory factors using 
various techniques and in different models. Much of our knowledge regarding ileus has 
come from experimental studies primarily using animal models. Woods et al. carried out 
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experiments on monkeys where electrodes were attached to the stomach, small intestine, 
right colon and sigmoid colon to get information on the pattern of recovery of ileus137. 
They found that even the laparotomy incision itself led to a reduction in myoelectrical 
activity. They also found that peristaltic inhibition was short lived in the stomach and 
small bowel but lasted 24 hours on the right side of the colon and 72 hours in the 
sigmoid. They showed good correlation between the return of myoelectrical activity in 
the sigmoid and the passage of the first bowel motion which is often used as a more 
clinical endpoint for the resolution of ileus. 
 
The same group continued their research in the monkey model and found no difference in 
the duration of ileus with the extent, site or duration of operation152. These findings are in 
contrast to traditional views held by many surgeons that ileus is made worse by 
prolonged exposure and handling of the intestines. The authors suggest that the parietal 
peritoneum plays an important role in the pathogenesis rather than the visceral 
peritoneum. This view is supported by the findings of Lindquist who reported that blood, 
turps or pus injected into the retroperitoneum produces prolonged ileus implicating the 
peritoneum as a major part of the process153. Following these animal experiments similar 
studies were carried out using implanted seromuscular electrodes in human patients with 
complete validation of the previous animal work138. As well as studies measuring 
myoelectrical activity, investigators have used radiotelemetering capsules to measure 
intra-luminal pressure and radio-opaque markers to look at transit through the 
gastrointestinal tract. Using these techniques Wilson also found no relation between 
duration of operation and length of ileus139. 
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In contrast to these studies there have been experimental studies which have suggested a 
link between manipulation of the bowel and ileus. Kalff et al. found that in the rat model 
there was an increase in inflammatory cell infiltrate within the intestinal muscularis 
proportionate to the degree of trauma to the intestines154. They also demonstrated a 
progressive decrease in muscle function in response to increasing degrees of 
manipulation. The findings are consistent with those of Beuno et al. who found that 
handling of small intestine in rats led to a reduced electrical activity compared with 
laparotomy alone155. The link between manipulation and inflammatory response in the 
small intestine is further demonstrated in a study by Schwarz et al156. It is also suggested 
that the increased wall permeability and bacterial overgrowth related to ileus leads to 
bacterial translocation and further morbidity157-159. 
 
It is difficult to reconcile these contradictory findings, however the studies which support 
the role of manipulation in ileus come from animal studies of small bowel. We know that 
the rate-limiting step in the recovery of function is the left side of the colon. Furthermore 
the colon is more dependent on the extrinsic nervous system and does not act as a 
‘peristaltic syncytium’ lacking the gap junctions of small bowel smooth muscle. This 
may well explain the lack of correlation between the experimental data and clinical 
studies.  
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Analgesia 
The role of postoperative analgesia in the duration of ileus has been found to be one of 
the most important therapeutic targets. It has previously been mentioned that opioids play 
a part in the pathogenesis of ileus. Experimental work has shown that the effects of 
opioids are mediated primarily at receptors within the GI tract and that spinal and 
cerebral receptors have less of a role160-162. Endogenous opioids are released as part of the 
stress response to surgery and act at mu-receptors in the bowel lead to inhibition of 
peristalsis. This natural effect can be further increased by the use of exogenous opioids in 
the postoperative analgesic regime. In an attempt to reduce the use of opioids other 
anaesthetic techniques have been employed to good effect.  
 
The use of epidural analgesia and its effect on the duration of ileus will be expanded on in 
a future chapter but it has proved the single most effective strategy to reduce the duration 
of ileus. Epidural local anaesthetics appear to block the inhibitory afferents involved in 
the spinal reflex. In 6 of 8 studies looking at the effect of epidural local anaesthetics ileus 
was found to be significantly reduced163-170. In the 2 studies which did not show a 
significant difference, one used low thoracic epidurals which may not have covered all of 
the necessary dermatomes for abdominal surgery and the other used the epidural for only 
24 hours rather than the 72 hours used in the other trials. 
 
Minimally invasive surgery 
With the introduction of laparoscopic surgery in the early 1990’s surgeons noticed as a 
result a reduction in ileus. It is suggested that this reduction in ileus is due to both 
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reduced manipulation and exposure of the bowel and a reduction in the inflammatory 
response. However following laparoscopic surgery postoperative recovery methods have 
often been very different to traditional care following open surgery making it difficult to 
determine which is exerting the most significant effect. 
 
In a study of 12 dogs subjected to laparoscopic or open right hemicolectomy Fazio’s 
group found a more rapid recovery of myoelectrical activity and a shorter time to first 
bowel motion in the laparoscopic group171. This was despite the duration of the procedure 
being double that in the open group. These findings have been validated by other studies 
using the same animal model172. 
 
Although an effect in relation to laparoscopic surgery seems clear its relative importance 
is still difficult to determine as studies on patients undergoing laparoscopic surgery with 
standardisation of the postoperative care package do not appear to show a difference in 
the duration of ileus173, 174.  
 
Early feeding and mobilisation 
The effect of early oral feeding following surgery is controversial and to some extent 
depends on the endpoints used to measure ileus. Some investigators prefer to combine the 
functional clinical endpoints of passage of bowel motion but also the time taken for 
patients to tolerate oral diet. With this in mind there is no doubt that patients who are 
offered food earlier in their recovery tolerate it more quickly than those who are offered 
diet only when there are indicators of bowel activity140, 175. Using only the endpoints of 
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passage of flatus or bowel motion oral feeding does not appear to play a major part in the 
duration of ileus144. 
 
Linked to the institution of oral diet is the traditional view that as well as fasting patients, 
nasogastric intubation reduced abdominal distension and the length of ileus. There is now 
strong evidence available that the routine use of NG tubes after elective colorectal 
surgery may prolong ileus and also increases the risk of other complications such as fever 
and atelectasis33. 
 
Another strongly held view with little scientific evidence to support it is that ambulation 
reduces the duration of ileus. It is in no doubt that early postoperative ambulation reduces 
the risk of other morbidities including deep venous thrombosis, chest infections and 
muscle wasting. However studies looking at the effect of ambulation on ileus do not 
support a significant effect. In a study of 34 patients who had electrodes placed at 
laparotomy there was no difference seen in myoelectrical activity between those who 
ambulated from day one and those who were kept on bed rest until day 4176. 
 
Therapeutic interventions 
Various therapeutic strategies have been employed to try to reduce ileus and too many to 
cover in the course of this review. It has been suggested that perioperative fluid excess 
can lead to gastrointestinal mucosal oedema with prolongation of ileus177. This will be 
covered in greater detail later in this introduction. 
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It has also been suggested that higher centre control of GI function can be affected by 
patients’ expectations and the way they are prepared for surgery. In a novel study of 20 
volunteers by Disbrow and colleagues, patients were counseled preoperatively to expect 
an early return of GI function and compared to a control group. They found that in the 
counseled group both ileus (2.6 days versus 4.1 days) and hospital stay (6.5 days versus 
8.1 days) were reduced178. 
 
A number of pharmacological agents have also been studied including propranolol, 
neostigmine, erythromycin, laxatives, metoclopramide and cholecystokinin, to name only 
a few, with either equivocal or negative results179. One class of drug with initially 
encouraging results with respect to ileus is peripherally selective opioid antagonists. As 
we have already seen the effect on peristalsis of both endogenous and exogenous opioids 
is inhibitory and mediated at receptors on the bowel wall. By blocking these receptors it 
is suggested that ileus could be reduced while still allowing adequate analgesia which is 
mediated through more central opioid receptors. The first of this class of drug to be 
trialed on patients was Alvimopan. In a study by Wolff et al. involving 510 patients 
Alvimopan was found to reduce time to recovery of GI function by 22-28 hours and 
reduced hospital stay by 20 hours180. They also found no significant difference in 
analgesia between groups suggesting that the systemic absorption of the drug was low. 
 
Conclusions 
Ileus remains a significant cause of postoperative morbidity for patients undergoing 
surgery and particularly for colorectal patients. It is one of the main delaying factors 
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affecting patient recovery and as such has been a target for research. The pathogenesis is 
multifactorial and the relative contribution of various factors is still controversial. 
Epidural local anaesthetics have certainly been shown to reduce ileus but the importance 
of minimally invasive techniques, early oral feeding and opioid sparing analgesic regimes 
is still unclear. While a variety of pharmacological therapies have been trialled few have 
shown any efficacy but recent work on peripherally selective opioid antagonists has been 
encouraging.  
 
 
1.10 AALGESIA 
 
Introduction 
Postoperative analgesia is an important component of any perioperative care regime. The 
ideal analgesic should be effective in treating postoperative pain, reduce the effects of the 
stress response and be safe to administer without significant complication. 
 
Following major abdominal surgery the majority of patients will require strong parenteral 
analgesia and the area of most interest in the recent literature has been the method of 
delivery for adequate analgesia. The two main strategies used have been either parenteral 
opioid analgesia delivered intravenously, intramuscularly or by the subcutaneous route, 
or epidural analgesia which delivers local anaesthetics and/ or opioids through a fine 
cannula into the epidural space. 
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Epidural analgesia was first described in 1900 and there are a number of theoretical 
advantages relating to its use in abdominal surgery181. Epidurals work by blockade of 
both nociceptive afferents and sympathetic efferent nerves and therefore may reduce pain 
and opioid requirement which may lead to reduced postoperative nausea. It is also 
suggested that by blocking the spinal reflex arc thought to be a major cause of ileus that 
bowel motility may well be improved. 
 
In support of the theoretical advantages experimental work has shown that epidural local 
anaesthetics suppress perioperative adrenaline and noradrenaline production182-184. In 
addition plasma levels of ACTH, cortisol, aldosterone and glucose are all reduced 
postoperatively in patients with epidural analgesia as opposed to other forms of analgesia 
indicating an attenuation of the stress response185. Despite these encouraging 
experimental results when looking at more clinically based endpoints the efficacy of 
epidural analgesia is less clear cut. 
 
Ileus 
The one area where the effect of epidural analgesia is not in question is with regard to 
intestinal motility postoperatively. As mentioned previously postoperative ileus is a 
frequent cause of morbidity for patients undergoing major abdominal surgery and can 
lead to nausea, vomiting, abdominal distention and abdominal pain as well as a delayed 
discharge from hospital. 
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In a recent Cochrane review 9 studies reported duration of ileus as an endpoint when 
comparing epidural analgesia with parenteral opioids186. These studies included a total of 
406 patients and only one of the studies did not report a statistically significant difference 
between the groups. The other studies all showed a consistent reduction in the duration of 
ileus in favour of epidural analgesia and this has been supported in subsequent trials165, 
167, 169, 188, 189. The trials considered in the meta-analysis were all on patients undergoing 
open surgery however there is some evidence that the advantages may in fact disappear 
when considering laparoscopic colorectal surgery. One recent study which looked at 38 
patients undergoing laparoscopic colectomy found no difference in duration of ileus with 
the use of epidural analgesia189. Similar results were found by a separate centre which 
looked at 20 patients undergoing laparoscopic sigmoid colectomy170. 
 
Analgesia 
With respect to the analgesic effects of epidurals, trials have considered a number of 
different areas. Firstly people have looked at the most effective regimen for delivering 
epidural analgesia. These have been using an opioid, a local anaesthetic or a combination 
of the two. It is fairly clear from the literature that on current evidence the combination of 
a local anaesthetic and an opioid gives superior analgesia to other regimens and that 
because of a synergistic effect doses can be reduced which in turn reduces the side 
effects169, 186, 190. 
 
It is also evident that the level of insertion of the epidural catheter is important so that the 
dermatomes crossed by the abdominal incision are included in the block. For most 
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abdominal surgery this requires an epidural to be placed around the level of the 8th 
thoracic vertebrae. Thoracic epidurals have been shown to give better analgesia than 
lumbar epidurals and postoperative analgesia is not affected by insertion before or after 
surgery190. 
 
When comparing the analgesic effect between epidural analgesia and patient-controlled 
analgesia with morphine the majority of trials suggest an improvement in analgesia with 
the epidural route. Absolute certainty of superior analgesia with an epidural is difficult to 
claim, primarily because the majority of studies to look at this area have suffered from 
poor methodology. Blinding of subjects has been a particular criticism and may well have 
lead to significant bias in the reporting of results. A number of studies also do not 
adequately report patients who either withdraw from the trial or incidences when epidural 
analgesia failed. Because of the lack of an intention-to-treat policy this is a further area 
where bias could be introduced. Despite these reservations the majority of trials do 
support superior analgesia with the use of epidurals. 
 
As part of a systematic review in the Cochrane Database, 5 out of 8 studies reported that 
combination epidurals provided better analgesia on day 1 when compared with PCA 
morphine186. No difference in postoperative nausea and vomiting was found between the 
two methods. In the Veterans Affairs Co-operative study, one of the largest single trials 
which included 1021 patients, epidural again proved better in terms of analgesia than the 
opioid alternative191. Finally in a meta-analysis of 100 articles published between 1966 
and 2000 epidural analgesia was found to give superior analgesia on each postoperative 
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day when compared to a variety of opioid regimes190. This trial included not only 
abdominal procedures but also orthopaedic and thoracic surgery but results were 
significant for each area individually. 
 
Complications 
The hope of those who have encouraged the use of epidural analgesia has been that with 
improved analgesia postoperatively an effect on morbidity and mortality would be 
realised. With the theoretical advantages and the changes in plasma markers suggesting 
an attenuation of the stress response, as well as improved analgesia allowing deeper 
respiration and patient mobilisation, a reduction in postoperative complications was 
expected. These theoretical advantages have not however been supported by clinical 
evidence. The MASTER trial looked at 915 patients deemed to be at high-risk of 
postoperative complications because of preoperative co-morbidity192. It found no overall 
difference in major morbidity or mortality when comparing epidurals to other analgesic 
techniques in patients undergoing major abdominal surgery. There was a difference seen 
in favour of epidural with respect to respiratory failure but this has not been confirmed in 
other trials. In a study of 150 patients undergoing abdominal surgery for cancer Jayr et al. 
found no difference in pulmonary complications or chest X-ray changes with the use of 
epidurals although forced vital capacity was less reduced postoperatively188. In the 
Veterans Affairs study no difference in complications or mortality was shown and this 
was further confirmed in the large meta-analysis by Block et al190. 
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The one area with respect to complications and epidural analgesia which is often not 
considered and is poorly reported in clinical trials is the complications relating to the 
technique itself. Studies report failure rates of anything between 4-50% of patients. In the 
MASTER trail detailed reporting of complications showed that of the 447 patients 
randomised to the epidural group only 225 managed to keep the epidural in for 72 hours. 
Of those who did not there were 13 failed insertions, 4 patients refused epidural, 45 had 
inadequate analgesia, 26 catheters dislodged, 5 leaked, nursing issues accounted for 5, 1 
patient had a high block, 1 catheter blocked, in 61 no reason was given and 66 gave other 
reasons192. This fairly clearly shows the range of problems associated with epidural 
analgesia. 
 
Conclusion 
Postoperative analgesia is an important part of the perioperative management of patients 
undergoing abdominal surgery. Epidural analgesia offers improved pain management at 
least in the first 24 hours when compared to parenteral opioid regimes and also reduces 
postoperative ileus in certain circumstances. However epidurals do not significantly 
reduce postoperative morbidity or mortality and the technique is not without its own 
complications. Despite this it has been widely adopted into colorectal practice in both the 
United Kingdom and in North America. 
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1.11 LAPAROSCOPIC COLORECTAL RESECTIO 
 
Introduction 
The first experimental laparoscopy dates back to 1901 when a German surgeon, George 
Kelling, used a cystoscope to examine the abdominal cavity of a dog. Since then the 
technique has steadily increased in its surgical application. Gynaecologists were among 
the first to apply the use of laparoscopy in humans using it first as a diagnostic tool and 
then proceeding to carry out tubal sterilisation. The first use of the laparoscope in General 
Surgery was again by a gynaecologist, Kurt Semm, who performed a laparoscopic 
appendicectomy in 1983193. However it was not until Phillipe Mouret carried out the first 
video-laparoscopic cholecystectomy in Lyon in 1987 that the technique was rapidly 
adopted into general surgical practice. Within 5 years laparoscopic cholecystectomy had 
largely replaced the open procedure because of the perceived benefit of speed and 
recovery time. In the enthusiasm to use the new technique adequate training was 
overlooked leading to reports of increased operative complications. In one report 
investigators found a 5-fold increase in bile duct injury following laparoscopic 
cholecystectomy compared with the open approach194.  
 
Despite the initial problems the use of the laparoscope has been applied to almost every 
abdominal procedure with varying degrees of success. The first report of a laparoscopic 
colectomy was in 1991195, 196, however due to the steep initial learning curve conversion 
to the open procedure was common at around 40%197, 198. The use of minimally invasive 
surgery was further questioned with a number of reports in the literature of metastases at 
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port-sites following resection for colorectal cancer199, 200. This was postulated to be due to 
specimen retrieval through the wound but metastases were also seen at distant port-sites 
with incidences from 1-21% reported201. Because of these early concerns laparoscopic 
colorectal surgery has been introduced mainly in the setting of randomised controlled 
trials which have given us a growing evidential basis for its use. Following the results of 
both large series and multi-centre randomised trials there is now a wealth of information 
regarding not just the short-term outcomes of recovery but also the long-term outcomes 
relating mainly to colorectal cancer. 
  
Long-term outcomes 
The delay in widespread adoption of laparoscopic colorectal surgery has primarily been 
due to the unknown effect on long-term outcomes in the treatment of malignant disease 
which forms the main part of colorectal practice. In the 15 years since the first 
laparoscopic colectomy there have been numerous series published with fairly large 
numbers of patients. These have to a great extent eased the fears of compromising the 
oncological resection using laparoscopy. 
 
In probably the largest single series experience to be published Di Palo et al. reported on 
599 patients treated with laparoscopic colectomy for colorectal cancer202. They give 
figures for morbidity (23.3%) and 5-year survival (81%) comparable with those for open 
surgery. They also report low rates of local recurrence for rectal cancers at 4.4% and only 
one port-site metastasis. Furthermore the conversion rate of 7% is a testament to their 
considerable experience and skill with the technique. 
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Lacy et al. published a randomised study of 219 patients with non-metastatic colon 
cancer treated by either laparoscopic or open surgery203. They found no significant 
difference in overall mortality but reported a significant improvement in cancer related 
mortality of 9% versus 21% in favour of the laparoscopic technique. The majority of the 
benefit seen was due to an increased loco-regional recurrence rate in the open group 
running at 14% which most would see as abnormally high. Despite this there was 
certainly no adverse effect on long-term outcome and there was again only 1 port-site 
metastasis identified. 
 
In a later randomised study by Braga et al. of 391 patients with colorectal cancer no 
difference in cancer-related survival or disease-free recurrence were noted between the 
two groups204. This study did report a difference in both postoperative complications 
(17.9% versus 36.3%, p=0.0005) and long-term morbidity (6.8% versus 14.9%, p=0.018) 
in favour of laparoscopic surgery. These differences were mainly attributable to wound 
infection postoperatively and higher rates of postoperative intestinal obstruction and 
incisional hernia. Braga also reported an improvement in quality of life scores up to 1 
year following surgery but further studies have failed to confirm these differences205. 
 
Another large trail published in the Lancet in 2004 from Hong Kong randomised 403 
patients undergoing sigmoid resection for colorectal cancer206. Again they found no 
difference in operative mortality, morbidity, cancer-related survival or lymph node 
retrieval rate between the two surgical techniques. The authors concluded that the use of 
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laparoscopic resection depends primarily on the perceived benefits in short-term 
recovery. 
 
Mega-trials and meta-analyses 
With the results of these series and medium-sized trials alleviating fears regarding the 
long-term outcomes for cancer patients some of the best evidence for both short and long-
term outcomes come from two large multi-centre trials as well as two meta-analyses 
which have drawn together all of the available information to date. 
 
The first of these is the COST trial which was a North American trial which randomised 
872 patients with colon cancer to open or laparoscopic surgery207. The median follow-up 
for the trial was 4.4 years. To try to avoid the problems of the learning curve for the 
technique only surgeons with at least a 20 case experience were included in the trial. 
They found with regard to recovery the median hospital stay was 5 days versus 6 days in 
favour of the laparoscopic group (p<0.001) and also that there was a shorter use of 
narcotics (3 versus 4 days, p<0.001). There was no difference in the postoperative 
complication or mortality rates. With regard to the oncological resection the study found 
no difference in resection margin or lymph node retrieval and rates of recurrence at 3 
years were similar (16% versus 18%) with <1% wound recurrence in both groups. 3-year 
survival also showed no significant difference. The COST study therefore showed no 
difference with regard to long-term outcomes in colorectal cancer but did show marginal 
benefits in terms of short-term recovery. 
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The other large multi-centre trial is the British CLASICC trial which randomised 794 
patients on a 2:1 basis to laparoscopic or open surgery respectively208. The findings were 
very similar to that of the COST study. There was a shorter duration of ileus noted as 
well as a shorter time to resumption of normal diet. This translated into a difference in 
hospital stay of 9 days versus 11 days in favour of the laparoscopic group. No difference 
was seen in quality of life or complications postoperatively and there was no difference in 
the completeness of resection or lymph node retrieval. The cautionary note to come out of 
the trial was that there was a high conversion rate of 29% and the patients who required 
conversion suffered both a delayed recovery and also an increase in the rate of 
complications. This led the authors to suggest that selection of patients for laparoscopic 
resection is crucial to reduce conversions and overall morbidity. 
 
Finally two meta-analyses have drawn together the available evidence from around 24 
published trials including nearly 7000 patients between them209, 210. These further confirm 
the benefits in terms of recovery with reduced duration of ileus, less pain and analgesic 
use, and shorter hospital stay. Furthermore the equivalence with respect to postoperative 
mortality, disease recurrence and cancer-related survival is no longer in doubt. 
 
Cost-effectiveness 
Despite showing short-term benefits for patient recovery incorporation of laparoscopic 
resection into widespread surgical practice depends also on its cost-effectiveness. Cost-
analysis of the laparoscopic technique has found the direct cost to be significantly higher, 
estimated at around $2100 (£1400) per procedure in one study206. This increase in cost is 
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due not only to the increased use of disposable instruments but also because the 
procedure takes significantly longer207, 208. This increased direct cost has been justified in 
several studies by savings made in relation to a shorter hospital stay with no significant 
difference in overall cost to the healthcare system211. However in a randomised trial of 
laparoscopic versus open colorectal resection from Sweden hospital stay was not 
significantly different between the two groups which led to a difference in cost to the 
healthcare system of €2244 (around £1500) per patient212. 
 
The influence of perioperative care 
It is clear from the evidence to date that the main benefits of the minimally invasive 
technique are focused on improvements in short-term recovery. It is also clear that these 
benefits particularly in relation to reduced hospital stay are important for the cost-
effectiveness of the procedure. Recently the short-term benefits on which the procedure is 
based have been brought into question by work carried out using multi-modal 
rehabilitation programmes. These regimes draw together different areas of perioperative 
care with a solid evidence base and combine them in a protocol to standardise and 
enhance patient recovery. This so-called ‘fast-track’ surgery has led to dramatic 
improvements in short-term recovery with hospital stay following open surgery of around 
3 days which is comparable to the best laparoscopic trials in the literature213. 
In a study by Kehlet’s group from Denmark 60 patients were randomised to either 
laparoscopic or open colorectal surgery with full patient and observer blinding174. They 
found no difference in pain score, fatigue, motor activity or cardiopulmonary function 
between the two groups. The median hospital stay was 2 days in each group. The results 
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from the study suggest that using an enhanced recovery programme may negate the 
benefits derived from laparoscopic surgery alone. 
 
In response to this study a further trial by King et al. was published in the British Journal 
of Surgery with 62 patients randomised on a 2:1 basis to either laparoscopic or open 
surgery211. They found that despite the use of a fast-track regime patients in the 
laparoscopic group had a shorter hospital stay (5 days versus 8 days, p=0.018). It could 
however be argued that the stay of 8 days postoperatively in the open group is much 
longer than that of other trials looking at fast-track recovery and the study suffered from 
the lack of blinding. 
 
With such contradictory results it is not clear whether there are still benefits to using 
laparoscopic surgery with multi-modal rehabilitation or whether the use of enhanced 
recovery will mean that laparoscopic resection is no longer cost-effective. The results of 
further trials looking at laparoscopic colonic resection with the use of an enhanced 
recovery regime are awaited. 
 
Conclusions 
Laparoscopic colorectal surgery has gained cautious acceptance from the surgical 
community since it was first described 15 years ago. It is well established that the 
oncological results for resection of colorectal cancer are comparable to that of the open 
technique. Port-site wound recurrence which was one of the initial concerns has been 
shown to be a rare complication and one which is also associated with the open 
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technique. The main benefits of the procedure, apart from the difference in cosmesis, 
which have been taken for granted rather than proven in large scale trials, has been in 
relation to patient recovery. In trials using traditional perioperative care laparoscopic 
resection has been shown to reduce ileus, pain and hospital stay however the benefits 
when using enhanced recovery protocols are a matter of current debate and ongoing 
research. It is also clear that laparoscopic resection is not for all-comers but rather if any 
benefit is to be derived patients must be well selected. 
 
 
1.12 THE EFFECT OF ITRAVEOUS FLUIDS O 
RECOVERY 
 
Introduction 
Fluid and electrolyte balance and the administration of intravenous fluids is an important 
but still poorly understood part of perioperative management. Despite a comprehensive 
understanding of some of the physiological principles involved the effect of co-morbidity 
in addition to the surgical stress response make fluid prescribing difficult. These 
difficulties are further exacerbated by contradictory findings throughout the medical 
literature. The effect not only of the volume, timing and route of fluid administration but 
also of the ideal composition of the fluid is still a matter of debate. 
 
Despite the complexity of the problem and the lack of agreement in the scientific journals 
the day-to-day management of surgical patients’ fluid requirements is often left to the 
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most junior member of the surgical team214, 215. Surveys of prescribing practice suggest 
that fluid charts are often not checked during daily ward rounds and may be inaccurate 
mainly due to shortages of nursing staff216. Furthermore the composition of different 
intravenous fluids is poorly understood with patients often prescribed water and salt 
grossly in excess of their normal maintenance requirements217. 
 
To begin to investigate the effect of intravenous fluid replacement on patient recovery 
during the perioperative period we must understand not only a patient’s requirements 
under normal conditions but also the effect of surgery. Normal water requirements are 
estimated at around 20-40mls/kg/day which is achieved through drinking (approximately 
1200mls), eating (1000mls) and water of oxidation (300mls). Of the 2L of oral intake and 
6-8L of gastrointestinal secretions only around 150mls is lost in the faeces. The rest is 
reabsorbed in the gastrointestinal tract although this may be altered by certain disease 
processes or following surgery. Important changes to normal homeostasis occur during 
the perioperative period. Preoperative fasting and anorexia can lead to water and salt 
depletion. There may be increased G.I. fluid losses through diarrhoea, bowel preparation 
or vomiting. So called ‘third space losses’ can result from the inflammatory response to 
surgery causing fluid to pool in the extra-vascular/ interstitial space and anaesthetic drugs 
can lead to reduced flow through the circulation with vasodilatation and reduced cardiac 
output. All of these factors need to be taken into account when addressing the problems 
of perioperative fluid management. 
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Recent evidence in the medical literature regarding the use of intravenous fluids and their 
effect on recovery has renewed interest in this vital component of patient management. 
Studies have examined the differing effect of type of fluid used in the perioperative 
context and also protocols for volume replacement. Both areas still require a lot of work 
before a final solution is reached however interesting advances have been made which we 
hope to investigate further during the course of our scientific work.  
 
What type of fluid is best? 
The type of fluid chosen depends on both the biological and physicochemical properties. 
The two types of fluid which are commonly compared are crystalloids and colloids. A 
crystalloid is an aqueous solution of mineral salts and other water-soluble molecules 
whereas a colloid solution contains larger non-soluble molecules such as gelatin and stays 
in the intravascular space for a much longer period of time. Crystalloids are thought to 
lead to significantly more tissue oedema which will theoretically increase diffusion 
distances, compress small capillaries and reduce organ perfusion. In a study which looked 
at crystalloid resuscitation during Whipple’s procedures Prien found that the jejunal 
specimen had increased water content when compared to using colloid218. Further studies 
suggest that colloids may cause less nausea, vomiting and postoperative pain which could 
all be attributable to reduced tissue oedema219, 220. Despite these positive findings the 
most recent meta-analysis to compare the use of crystalloids and colloids concluded that 
‘methodological limitations preclude any evidence-based clinical recommendations’221.  
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There is also controversy over the composition of fluids used. Recent evidence suggests 
that large volume administration of salt containing fluids, particularly normal saline but 
also including colloids dissolved in isotonic saline may be detrimental to patient 
recovery. When compared to more balanced solutions such as Hartmann’s and Ringer’s 
lactate, saline has been found to cause renal vasoconstriction and reduced glomerular 
filtration rate which means that it takes significantly longer to get rid of the excess 
sodium load222-224. Furthermore saline is associated with the development of 
hyperchloraemic acidosis due to the high concentration of chloride. This metabolic 
acidosis can cause a reduction in gastrointestinal perfusion as measured by gastric 
tonometry and has been shown in pigs to reduce gastric motility225, 226. Excessive sodium 
administration has also been associated with increased postoperative complications in 
colorectal patients although this study was a retrospective review and so does not prove a 
causal link227. 
 
How much fluid should be given? 
Most clinicians would agree that fluid administration for surgical patients is a fine 
balance between dehydration on one side and fluid excess on the other but there is 
continued discussion over which abnormality is predominant during the perioperative 
period. The argument for fluid restriction is that the metabolic-endocrine response to 
surgery is water and salt conservation mediated by aldosterone, the renin-angiotensin 
system and anti-diuretic hormone. Others would argue that because of the inflammatory 
response ‘third space losses’ dictate that you become relatively dehydrated and require 
extra fluid. This process would presumably be proportionate to the surgical insult and 
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may vary depending on the type of surgery. Shoemaker in the 1970’s and 80’s proposed a 
policy of resuscitating patients to supra-normal levels of circulatory function however 
excess fluid in the intravascular space can lead to increased fluid in the interstitial space 
and in turn to pulmonary and peripheral oedema with reduced systemic and local tissue 
oxygenation228. 
 
As previously mentioned the balance between inadequate fluid administration/ 
dehydration and excess fluid with oedema formation will vary depending on the type of 
surgery and the different components of the perioperative care package used. Studies 
carried out on day-surgery patients who received a pre-load of intravenous fluid to 
compensate for their period of fasting found that patients had significantly less PONV as 
well as postoperative pain229, 230. Patients receiving bowel preparation with no 
intravenous fluid replacement had a postural decrease in arterial blood pressure as well as 
a reduced urine output and increased creatinine when compared to patients who received 
a 2L crystalloid infusion79. These studies demonstrate clearly that fluid and electrolyte 
balance relating to different perioperative interventions can have a significant effect on 
recovery. Although this role in recovery is now recognised the best way to achieve 
optimal fluid balance remains unclear. 
 
The two competing theories of fluid restriction and maximal fluid resuscitation are often 
linked with different methods of managing perioperative fluid balance. While many use a 
standard fluid regime for uncomplicated elective patients with additional boluses guided 
by clinical endpoints, an alternative approach is the so called ‘goal-directed fluids’. 
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Although seen as competing strategies it is true to say that both are in fact goal-directed. 
Fluid regimes can be altered to make them biased towards a ‘conservative’ approach but 
always include the administration of additional fluid based on clinical endpoints such as 
blood pressure, pulse and urine output. The ‘goal-directed’ approach incorporates a more 
invasive assessment of circulatory function using an oesophageal Doppler monitor to 
calculate cardiac output. This method involves the placement of an ultrasonic probe in the 
oesophagus to calculate blood flow and cardiac output. Fluid is then titrated until the 
maximal stroke volume is reached which it is argued gives a more accurate and 
immediate method for responding to changes in fluid balance. Those who are sceptical of 
this method suggest that for patients who are often elderly with extensive co-morbidity 
this maximal cardiac workload throughout the intraoperative period may be detrimental. 
 
Fluid restriction 
The first to suggest a delay in recovery due to excess fluid was Mecray who carried out 
an animal study on dogs231. He found that gastric emptying time was significantly 
delayed in response to saline and low protein. He also showed that the change in motility 
was reversible using salt and water restriction and high protein intake. At autopsy dogs 
were found to have mucosal oedema affecting the gastrointestinal tract in response to 
excess saline and it was postulated that the oedema was the cause of the motility changes 
observed.  
 
These findings were tested in a clinical setting by Lobo who randomised 20 patients 
undergoing colectomy to either ‘restricted’ intravenous fluids or a ‘standard’ regime232. 
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The main difference in fluid administration occurred on the day of operation with a 
difference of 3L between the groups (3L versus 6L, p<0.0001). Patients in the restricted 
group gained significantly less weight in the postoperative period. Lobo reported a 
significant reduction in solid and liquid phase gastric emptying in the restricted group as 
well as a reduced time to first bowel motion (3 versus 4 days, p=0.001) and a shorter 
hospital stay (6 versus 9 days, p=0.001). He concluded that reducing postoperative 
gastrointestinal mucosal oedema was the mechanism for the improvement in GI function. 
The trial was criticised for the small number of patients and also due to the lack of 
blinding of those assessing eligibility for discharge which may have been a source of 
bias. Patients involved in the trial underwent a limited range of procedures meaning the 
results may not be generalisable. 
 
Following on from the Lobo trial Brandstrup et al. carried out a randomised, observer 
blinded trial of 141 patients undergoing colonic resection receiving standard or restricted 
(weight neutral) postoperative fluids233. As in the Lobo trial there was a significant 
difference in weight gain with the standard group gaining around 3kg on average. The 
difference in mean fluid volume on the day of theatre was 2.7L in the restricted group 
compared with 5.4L in the standard group (p<0.0005). They found a reduction in 
postoperative complications in the restricted group (33% versus 51%, p=0.013) with 
cardiopulmonary (7% vs 24%, p=0.007) and tissue healing (16% vs 31%, p=0.04) 
complications accounting for the major difference. They also demonstrated a dose 
dependent relationship between fluid volume and frequency of complications. 
Brandstrup’s group did not report duration of postoperative ileus or hospital stay. 
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In the final study to look at fluid restriction Nisanevich randomised 152 patients 
undergoing elective abdominal surgery to restrictive or liberal intraoperative fluids234. 
Again there was a significant difference in fluid volumes on the day of theatre (1408 
versus 3878mls, p<0.001) and also in patient weight gain (0.5 versus 2kg, p<0.01). 
Patients in the restrictive regime were found to have less complications (mainly 
infectious or cardiovascular), faster return of bowel function and shorter hospital stay (8 
versus 9 days, p=0.01). In this study the surgical team used a traditional recovery 
protocol which is evident from the duration of hospital stay. 
 
Goal-directed fluids 
One of the first studies to use goal-directed fluids using an oesophageal Doppler was 
carried out on patients with normal left ventricular function undergoing coronary bypass 
grafting235. The study found a significant reduction in intensive care and overall hospital 
stay in the protocol group. The next study looked at using the technique in patients 
undergoing surgery for proximal femoral fracture and also showed a reduction in hospital 
stay236. As we know maintenance of fluid balance is different for different types of 
surgery and so perhaps more relevant data comes from studies using the technique for 
patients undergoing colorectal resection. 
 
The first of these was a study of 57 patients randomised to either oesophageal Doppler 
management or standard fluids during bowel surgery237. There was no statistically 
significant difference in the volumes of fluid used although more colloid was used in the 
Doppler group. The authors reported fewer complications in the Doppler group although 
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the study is not powered for this endpoint. They did not find any difference in time to 
tolerating diet or time to discharge. 
 
The next study was of 100 patients undergoing gynaecological, urological or GI surgery 
with an estimated blood loss of greater than 500mls238. Patients were randomised to either 
standard or goal-directed fluids with only a small difference in overall volume (5420 
versus 4775mls). The difference in fluid volume is due to a difference in colloid solution 
infused. Gan et al. reported an earlier return to diet (3 versus 5 days, p=0.01) and a 
shorter hospital stay (6 versus 7 days, p=0.03). Information was not given on differences 
in postoperative fluid management and a traditional care pathway was used making it 
difficult to interpret the results. The difference in fluid shifts among the population 
studied (blood loss of greater than 500mls) would not be expected in a standard elective 
colorectal population but may indicate a benefit to the technique when fluid shifts are less 
predictable. 
 
In one of the most recent trials Wakeling et al. looked at 128 colorectal patients managed 
with either intraoperative oesophageal Doppler or central venous pressure monitoring239. 
Patients in the Doppler group received more fluid (5 versus 4L) although again 
postoperative fluid management is not recorded. The authors report a shorter hospital stay 
(10 versus 11.5 days, p<0.05), shorter time to tolerating diet (6 versus 7 days, p<0.001) 
and reduced GI morbidity (45 versus 14%, p<0.001). One possible criticism of the trial is 
that there were more left sided colonic resections and more stomas formed in the control 
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group which could account for the difference in hospital stay which was also longer than 
hospital stays seen in most other studies. 
 
Finally Horgan et al. published a double-blind randomised trial of 108 patients 
undergoing elective colonic resection290. They compared Doppler-guided fluid therapy to 
fluids given at the discretion of the anaesthetist and found shorter hospital stay (7 versus 
9 days, p=0.005), and reduced postoperative complications (2 versus 15%, p=0.043) in 
the intervention group.  
 
Conclusions 
It is difficult to come to firm conclusions regarding the best method to optimize 
perioperative fluid management. While studies have so far been inadequate to show any 
clear difference between colloids and crystalloids the differences in which fluid is used 
may be a confounding factor in studies of fluid volume. It is clear that fluid management 
can have an effect on postoperative recovery and that management needs to be tailored to 
the exact nature of the surgery being carried out. 
 
In relation to colorectal surgery the evidence seems to suggest that if large fluid shifts can 
be avoided patient recovery may be improved. This may be achieved by compensating 
for the dehydrating effect of bowel preparation and preoperative fasting or by avoiding 
the use of bowel preparation and limiting the duration of fasting. Initial studies looking at 
conservative intraoperative fluid protocols suggest that postoperative ileus, complications 
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and hospital stay may all be reduced and that the possible mechanism is through reduced 
gastrointestinal and tissue oedema. 
 
Studies looking at the effect of goal-directed fluids using oesophageal Doppler 
monitoring suggest that the technique may be of use in higher risk patients and when the 
potential for large fluid shifts is greater. It is difficult to compare the results with those of 
fluid restriction trials as the postoperative management of patients is so variable between 
the studies. It is also difficult to explain how such small differences in fluid volumes in 
these trials can lead to the differences suggested in postoperative recovery. 
 
 
 
 
1.13 FAST-TRACK SURGERY 
 
Introduction 
The idea of ‘fast-track’ surgery has been developed primarily by Professor Kehlet’s 
group in Denmark. The aims of the approach are to attenuate the surgical stress response 
and reduce end organ dysfunction through an integrated recovery pathway. This pathway 
should incorporate perioperative strategies with a proven evidence base to reduce hospital 
stay following surgery and allow a quicker return to baseline function. In recent times 
many of the individual elements which make up perioperative care have been studied 
with traditional practice challenged. Mechanical bowel preparation for instance does not 
appear to have any significant benefit and may simply make optimisation of fluid balance 
more difficult by adding to the dehydration experienced during the period of preoperative 
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fasting79, 89, 90. Nasogastric tubes have been shown to increase respiratory complications, 
cause significant discomfort and delay the introduction of oral diet33. This change in 
practice has allowed others to introduce early oral feeding which has proven safe and 
well tolerated following abdominal surgery144. Other factors which have allowed the 
successful introduction of early oral diet have included better antiemetic strategies and 
epidural local anaesthetics which reduce the duration of postoperative ileus186. With the 
use of dynamic pain regimes and the introduction of early oral diet patients may also be 
more able to comply with early mobilisation, regaining their independence necessary 
before considering discharge home. It is clear then from this wealth of evidence that the 
success of a single strategy in isolation may be limited but that as part of a multimodal 
rehabilitation regime the potential benefits are significant.  
 
The initial evidence 
Before the birth of fast-track surgery others had already recognised the potential benefits 
of using a coherent pathway to direct and standardise perioperative care. By introducing a 
clinical pathway with many traditional recovery principles Pritts et al. found that patients 
were discharged from hospital up to 2 days earlier following colonic surgery240. The 
length of hospital stay was still around 8 days as more modern interventions were not 
employed but it served to show that the protocol approach to recovery had merit. They 
also showed through a cost-analysis that the shorter hospital stay reduced cost from 
around $20,000 to close to $14,000. 
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Much of the experience with fast-track surgery comes from case series and single unit 
experience. In one of their first publications on fast-track Kehlet’s group studied 57 
consecutive patients undergoing elective colonic resection241. They reported that the 
majority of patients moved their bowels within 48 hours of surgery and that the median 
hospital stay was 2 days. Of the 57 patients, 9 patients required readmission but the 
authors stated that no life-threatening complications were delayed in their presentation. 
 
Following this early experience Kehlet later published a larger series of patients 
undergoing colonic resection and treated in a single centre using a fast-track regime213. 
He compared 260 patients of which half had been treated at another University hospital in 
Copenhagen using a more traditional strategy. After analysis of the two groups he found 
that the fast-track group was comprised of patients with a significantly higher ASA grade 
and that there was a preponderance for left sided colonic surgery both of which it could 
be argued would delay recovery in the fast-track group. Despite these differences the fast-
track group had a shorter time to first bowel motion (2 versus 2.5 days, p<0.05) and a 
significantly shorter median hospital stay (2 versus 8 days, p<0.05). In addition they 
found that patients in the fast-track group had less postoperative complications (25% 
versus 45%, p<0.05) due to a reduction in cardiopulmonary and wound complications. 
Readmissions were higher in the fast-track group at 20% versus 12% in the traditional 
group (p>0.05). 
 
Following on from these studies other groups around the world attempted to translate the 
benefits experienced with fast-track recovery into their own practice. One of the largest 
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of these series was a French study of 132 elective colorectal patients treated with fast-
track rehabilitation242. They reported hospital stay of 4 days and a readmission rate of 
11%. This was significantly quicker when compared with historical controls with a 
reduction in complications also seen. As well as the French study further series from 
Germany, Italy, Sweden, the United Kingdom and North America have all reported 
reductions in hospital stay to between 3 and 5 days145, 148, 243-245. Although other 
investigators have failed to achieve hospital stays as short as 2 days significant 
improvements have been duplicated and readmission rates have been reduced to more 
acceptable levels. 
 
As well as a growing experience in other units the principles of fast-track surgery have 
been applied to an increasing number of procedures and disciplines246-248. Initial 
criticisms of fast-track studies included the selective population with only straight-
forward colonic resections included and in an otherwise young, fit population. Similar 
benefits have since been demonstrated when fast-track is applied to more major surgery 
including major colorectal, pelvic and re-operative surgery249, 291. Studies looking at fast-
track in elderly surgical populations have also found that recovery can be significantly 
enhanced although suggest that the age group less than 70 years gain the most benefit 
from the approach145, 250, 292. Fast-track principles have been applied to nephrectomy, 
aortic abdominal aneurysm repair and gynaecological surgery with similar benefits in 
recovery recorded251-254. 
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The aims of a multimodal rehabilitation programme are to reduce the stress response to 
surgery which leads to hypermetabolism and an overall catabolic result. Those sceptical 
of fast-track recovery have argued that the majority of the evidence in support of fast-
track is from non-randomised series from units with an enthusiastic interest which may 
introduce significant bias. Blinding trials in this setting has also proven difficult. In 
addition it is argued that simply looking at the endpoint of hospital stay does not 
necessarily reflect an improvement in recovery and a reduction in the metabolic-
endocrine response to surgery. It may simply be that clinicians are discharging patients 
earlier in their recovery. Evidence to refute this argument comes from studies which have 
looked at a range of other endpoints rather than simply hospital stay. In a study 
comparing gastrointestinal motility in fast-track surgical patients compared to healthy 
volunteers using scintigraphy Basse found no difference in excretion of tracer between 
the groups147. These findings suggest that strategies to reduce the duration of ileus are 
proving successful and that the differences in time to first bowel motion are not simply 
due to sigmoid emptying. In a non-randomised study comparing 14 fast-track patients 
with 14 control patients after colonic resection Basse et al. found that lean body mass and 
postoperative exercise performance were preserved with fast-track recovery while the 
control group noticed significant reductions in both255. In a further study looking at 
patients after discharge from hospital Hjort et al. reported that fast-track patients 
experienced an earlier resumption of normal activities, a reduced need for daytime sleep 
and no increased use of primary care when compared to a control group256. It has also 
been suggested that ‘fast-track’ rehabilitation can lead to improved preservation in cell-
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mediated immunity postoperatively293. These more objective findings it has been 
suggested support the claims of a reduction in the surgical stress response. 
 
Randomised trials 
While there is a wealth of experience of multimodal rehabilitation through case-
controlled series the number of truly randomised trials has been limited. The first 
randomised controlled trial was carried out by Delaney et al. and comes for the Cleveland 
Clinic in Florida145. They randomised 64 patients to either a fast-track regime or a 
traditional care package following colorectal resection and showed that hospital stay was 
reduced (5.4 versus 7.1 days, p=0.02). They found no difference in readmission rates, 
pain scores or quality of life between the two groups including no difference in 
complications, although the study is not powered for this endpoint. Interestingly they 
found that patients managed by surgeons with an experience of fast-track regimes spent 
significantly less time in hospital regardless of which group they were randomised to. 
This shows not only that readiness for hospital discharge has a subjective element to it 
but also that there is a learning curve with the approach. The benefits demonstrated are 
more modest than in other studies which may be due to the use of PCA morphine rather 
than epidural analgesia. However the authors go on to suggest that despite this modest 
difference 1.2 million hospital days could be saved in the United States using this 
approach for colorectal surgery alone. 
 
Two further randomised trials using fast-track recovery with colorectal surgery come 
from McFie’s group in Scarborough, U.K. The first trial to be published randomised 25 
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patients to fast-track or control and found that hospital stay was reduced from 7 to 3 days 
(p=0.002)148. They also found that pain scores and fatigue were reduced and that there 
was earlier tolerance of oral diet in the fast-track group. This study was criticised as the 
control group were not treated with epidurals and so it was argued the study was really a 
study of epidural analgesia over PCA morphine. It is a common difficulty with fast-track 
trials to separate the effects of single interventions from the whole pathway. McFie 
followed this trial by reporting a second similar study of 39 patients with both groups 
treated with epidural analgesia146. In support of his previous findings hospital stay was 
reduced from 7.5 days to 5 days (p=0.027) although no explanation was given for the 
increased length of stay in the fast-track group in comparison with the previous trial. 
 
Conclusion 
Fast-track recovery protocols have been shown to significantly enhance perioperative 
recovery in a range of different settings. Following colorectal surgery hospital stays of 2-
3 days have been reported where previously 8-10 days would have been normal practice. 
Multimodal rehabilitation appears to positively influence the surgical stress response with 
reductions shown in duration of ileus, complications, pain, postoperative exercise 
tolerance and activities of daily living. The advances in recovery found using fast-track 
regimes following open abdominal surgery have also led clinicians to question the 
additional benefits of laparoscopic surgery. The application of laparoscopy to colorectal 
surgery has been based primarily on improvements in short-term recovery however if 
discharge after open surgery is possible after 2 days then the additional expense of 
laparoscopy may be difficult to justify. In one randomised and blinded trial comparing 
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laparoscopic and open surgery in patients enrolled in a fast-track programme no 
difference was found in cardiopulmonary function, gastrointestinal function, pain, fatigue 
scores or hospital stay174. 
 
Research into perioperative recovery continues to be a rapidly changing field. As 
different parts of the fast-track regime are investigated further, new strategies are adopted 
to reflect changing knowledge. Pharmacological strategies to further reduce ileus such as 
peripheral opioid antagonists have shown promise. Although the area of fluid 
optimisation has been shown to exert an effect on recovery the ideal fluid regime is yet to 
be defined. Further research in manipulation of the numerous cascades resulting from 
injury is ongoing with the aim of attenuating the deleterious effects while enhancing 
those that are beneficial. Technological advances will also play an increasing role through 
laparoscopic surgery and beyond but in all these areas evidence-based practice should 
remain the foundation on which any advances are built. 
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ITRAVEOUS FLUID THERAPY 
 
The main focus of this research work is in the area of intravenous fluid therapy. Our aim 
is to determine the effect of postoperative intravenous fluid restriction on recovery 
following elective colorectal surgery. The first part of the work will be to carry out a pilot 
study. The aim of the pilot study will be to assess whether a postoperative fluid and 
sodium restriction regime can be applied safely and effectively to our clinical practice. 
The secondary aim of the pilot study will be to ensure that the relevant systems and data 
collection methods are in place prior to the commencement of a randomised trial. 
 
The aim of the randomised trial will be to investigate the effect of postoperative fluid 
restriction on recovery following elective colorectal surgery in patients managed with 
intraoperative fluid restriction. The primary endpoint for the trial will be length of 
hospital stay. Secondary endpoints will include duration of ileus, complications, pain and 
nausea scores, analgesic and antiemetic requirements.  
 
LAPAROSCOPIC-ASSISTED SURGERY 
 
Following the randomised trial looking at the effect of intravenous fluid restriction we 
will look at other factors involved in recovery following major abdominal surgery. The 
first of these factors is the use of laparoscopic-assisted surgery. The aim of this study will 
be to investigate whether laparoscopic-assisted colorectal surgery improves recovery with 
the use of a multi-modal rehabilitation regime. This will be achieved by comparing the 
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outcome data for patient randomised to the intravenous fluid trial who had either open or 
laparoscopic-assisted colorectal resection. From these results we hope to be able to 
determine whether the type of surgery or the perioperative recovery pathway is the most 
important factor in immediate postoperative outcome. 
 
FAST-TRACK LIVER RESECTIO 
 
Following on from our experience using ‘fast-track’ recovery we want to investigate the 
effect of a multi-modal recovery regime in an area of surgery where it has not previously 
been applied. The aim of this study is to determine the effect of fast-track recovery on 
patients undergoing liver resection for colorectal liver metastases. We will analyze 
outcome data for a consecutive series of patients undergoing open liver resection using a 
fast-track regime and compare this with other series published in the medical literature. 
 
COLOIC RESECTIO 
 
The aim of our final area of research is to investigate the effect of the colonic resection 
itself on recovery of colonic function following major open abdominal surgery. We will 
compare a series of patients undergoing open liver resection with no intestinal 
manipulation or colonic resection to a series of patients undergoing open colorectal 
resection. The primary endpoint of the study will be the duration of postoperative ileus. 
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3.1 Introduction 
 
Intravenous fluids play an important role in the perioperative management of patients 
undergoing major abdominal surgery. Until recently there was little evidence available on 
the effects of intravenous fluids in the perioperative period to guide clinical practice. This 
has since changed due to two main factors. Firstly the introduction of multimodal 
rehabilitation programs has led to clinicians re-examining interventions made around the 
time of surgery to assess their effect on recovery. In addition there have been two trials 
published in the surgical literature on the area of intravenous fluid administration which 
have stimulated renewed interest.  
 
The first paper by Lobo was published in the Lancet in 2002 and was the catalyst for the 
multi-centre randomised controlled trial reported in this thesis232. The study by Lobo was 
based on observations made in the clinical nutrition unit in Nottingham that elimination 
of oedema in postoperative patients led to an increase in serum albumin and possibly an 
earlier return of gastrointestinal function. The investigators postulated that restricting 
intravenous fluid may lead to a more rapid recovery from surgery. These findings were 
supported by previous animal studies by Mecray which found that gastric emptying was 
prolonged in dogs infused with saline to provoke hypoalbuminaemia231. The changes in 
gastric emptying time were then reversed by salt and water restriction.  
 
Lobo et al. carried out a randomised controlled trial comparing 10 patients treated with 
intravenous fluid restriction and 10 patients treated with ‘standard care’ following 
 101
elective colorectal surgery. Patients in the restricted group were limited to 2 litres of 
intravenous fluid and 77mmol of sodium per day while patients in the control group 
received fluids in accordance with the standard practice in the unit. The primary endpoint 
of the study was gastric emptying measured using radio-labeled contrast. The 
investigators found a significantly reduced gastric emptying time in the restricted group 
(difference between medians for solid and liquid phase T50 of 56mins and 52mins 
respectively, p=0.017). They also reported a significant difference in return of 
gastrointestinal function (median 4 vs. 6.5 days, p<0.001) and hospital stay (median 6 vs. 
9 days, p<0.001) in favour of the restricted group. These findings suggested that both 
ileus and hospital stay could be dramatically reduced in colorectal patients using a 
restricted intravenous fluid and sodium regime. 
 
Since its publication the Lobo trial has drawn a number of criticisms. In the introduction 
to the paper the authors admit that the study was prompted by observations they had 
already made which would suggest bias towards the restriction regime. The study was 
non-blinded which makes any potential for bias in the results even greater, especially as 
the endpoint of hospital stay is often dependent on a subjective assessment of patient 
recovery. The study was further criticized for having a small patient population all of 
whom were fairly fit and undergoing a limited number of procedures.  
 
The second study by Brandstrup in the Annals of Surgery was published after the 
commencement of our own fluid trial in late 2003233. This study examined the effect of a 
restricted intravenous fluid regime on postoperative complications following elective 
 102
colorectal surgery. No data regarding duration of ileus or hospital stay was presented. The 
findings of the trial suggested that there was an increase in postoperative complications in 
the standard group, particularly respiratory and wound complications. 
 
In response to the Lobo trial and taking into account its limitations we decided to 
undertake a multi-centre, single-blinded, randomised controlled trial to test the hypothesis 
that restriction of intravenous fluid and sodium leads to a more rapid return of 
gastrointestinal function and shorter hospital stay for patients undergoing elective 
colorectal surgery.  
 
While submitting applications for the funding of the trial and following ethical approval 
in the coordinating centre we commenced a pilot study to confirm that the fluid 
restriction regime could be applied to our clinical practice both safely and effectively. 
The pilot study also allowed us to ensure that the necessary systems were in place to run 
the subsequent randomised controlled trial successfully. 
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3.2 Patients and methods 
 
We carried out a prospective case-controlled series of 10 consecutive patients undergoing 
elective colorectal surgery using a restricted intravenous fluid and sodium regime and 
compared this with a retrospective series of 10 consecutive patients managed with 
‘standard care’. The study was carried out in one surgical centre and with a single 
operating surgeon over a 4-month period preceding the commencement of the multi-
centre randomised trial reported later in this thesis. All patients undergoing elective 
colorectal resection with primary anastomosis were eligible unless they had significant 
renal impairment, suffering severe physical disability and in long-term care, an insulin 
dependent diabetic or undergoing total colectomy, abdominoperineal resection of the 
rectum, or low anterior resection requiring a defunctioning stoma. 
 
Patients were consented after receiving a patient information sheet devised for the 
randomised trial (See Appendix I, II). Patients were allowed to drink up to 2 hours prior 
to their operation. Patients did not receive bowel preparation except for those having left-
sided surgery who had a phosphate enema the night before and the morning of surgery. 
This regime was a change in practice instituted in line with recent evidence and avoided 
preoperative dehydration as a factor in patients’ perioperative fluid balance. All patients 
received antibiotic and DVT prophylaxis. 
 
A standardized anaesthetic protocol was used in all patients and normothermia was 
maintained throughout the procedure. Patients were given a restricted intraoperative fluid 
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regime consisting of 4 per cent dextrose, 0.18 per cent saline at 10ml/kg/hr plus 3 x 
measured blood loss. No nasogastric tubes or drains were placed. 
 
An analgesic protocol was developed which utilized PCA morphine (1mg bolus, 5 minute 
lockout) for the first 48 hours. Regular Paracetamol was prescribed (1g four times daily, 
orally or rectally) and oral NSAIDs were used for breakthrough pain after the PCA had 
been discontinued. 
 
Oral fluids were encouraged in all patients immediately following anaesthesia and oral 
diet was commenced on the first postoperative day as tolerated. All patients were treated 
with a postoperative fluid and sodium restriction regime consisting of 2 litres of 4 per 
cent dextrose and 0.18 per cent saline per day. The intravenous fluid protocol closely 
mirrored the regime used in the Lobo trial. Intravenous fluids were stopped after the first 
postoperative day unless otherwise clinically indicated. Patients had daily biochemistry 
and haematology measurements. Active mobilization and chest physiotherapy was 
commenced on the first postoperative day. 
 
Patients were discharged by the consultant surgeon once all discharge criteria had been 
met. To be considered fit for discharge patients had to be apyrexial, fully mobile, passing 
flatus or faeces and using oral analgesics only for pain. The pilot study allowed all 
members of the team time to adjust to the changes in discharge practice as changing 
expectations of both medical staff and patients is a major part of fast-track recovery. A 
new follow-up policy was also instituted during the pilot study which involved the 
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research nurse phoning patients at home daily for the first two weeks followed by an 
outpatient review at 30 days. This ensured that complications out of hospital were not 
missed. 
 
The results from the pilot study were compared to retrospective data for 10 patients 
undergoing elective colorectal surgery immediately prior to the start of the pilot study. 
The results were not analysed statistically as the aim of the study was not to prove 
significance but rather to assess the ability to use a fluid restriction regime and follow a 
fast-track protocol in preparation for a larger randomised controlled trial. 
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3.3 Results 
 
Of the 10 patients treated using the fluid restriction regime the median age was 72 (i.q.r. 
64-81) years compared with 75 (70-85) years in the control group. There were no obvious 
differences in sex ratio or ASA grades between the two groups. There were a greater 
number of left-sided resections in the fluid restriction group (Table 3.1). 
 
Patients in the fluid restriction group had their intravenous fluids discontinued earlier 
than the control group (median day 1 (1-1) versus day 3 (2-3)). The cumulative total 
intravenous fluid volume from day 0-3 was 4.5 (4-5) litres in the restricted group versus 
8.05 (6.5-11.5) litres in the control group. The cumulative total intravenous sodium from 
day 0-3 was 362 (306-428) mmol in the restricted group versus 763 (533-1056) mmol in 
the control group. No patients required a perioperative blood transfusion. There were no 
adverse events related to the use of the fluid and sodium restriction regime (Table 3.2). 
 
The trend suggested a shorter time to first bowel motion (4 (3-5) days versus 5.5 (4-8) 
days) in the restricted group. The median day of discharge for patients in the restricted 
group was day 6 (5-6) versus day 7.5 (6-9) in the control group. 1 patient in the restricted 
group developed an enterocutaneous fistula and another patient suffered a postoperative 
myocardial infarction. There were no complications in the standard care group. No 
patient developed a complication following discharge from hospital and there were no 
readmissions during the pilot study. There were no postoperative deaths within 30 days of 
surgery. 
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Table 3.1 Baseline Characteristics for patients in fluid and sodium 
restriction pilot study 
 
 
 
 Fluid restriction patients Control patients 
N 10 10 
Age (years) 72 (64-81) 75 (70-85) 
Sex 
Male 7 6 
Female 3 4 
ASA Grade 
1 1 0 
2 6 7 
3 2 3 
4 1 0 
Operation 
Right hemicolectomy 2 5 
Left hemicolectomy 3 1 
Anterior resection 5 4 
Reversal of Hartmann’s 1 0 
 
Values are median (interquartile range) 
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Table 3.2 Intravenous fluid and sodium daily quantities and cumulative 
totals for patients in the fluid and sodium restriction pilot study 
 
 
 
 
  Fluid restriction patients Control patients 
  Median (IQR) Median (IQR) 
Day of operation 
IV Fluids (l) 2.45 (2.00, 2.50) 3.00 (2.00, 3.50) 
Na+ (mmol) 246 (169, 317) 339 (302, 456) 
Day 1 post-op 
IV Fluids (l) 2.00 (2.00, 2.50) 2.50 (2.00, 3.50) 
Na+ (mmol) 60 (60, 77) 187 (77, 308) 
Day 2 post-op 
IV Fluids (l) 0 (0, 0) 2.00 (2.00, 2.50) 
Na+ (mmol) 0 (0, 0) 154 (154, 231) 
Day 3 post-op 
IV Fluids (l) 0 (0, 0) 0.50 (0, 1.50) 
Na+ (mmol) 0 (0, 0) 0 (0, 154) 
Cumulative total 
IV Fluids (l) 4.50 (4.00, 5.00) 8.05 (6.50, 11.50) 
Na+ (mmol) 362 (306, 428) 763 (533, 1056) 
 
Values are median (interquartile range) 
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3.4 Discussion 
 
The results of the pilot study confirmed that using the protocol developed for the 
randomised controlled trail we were able to safely restrict intravenous fluid and sodium 
during the perioperative period. It also suggested that using a restricted fluid regime may 
reduce the duration of postoperative ileus and allow a more rapid discharge from hospital. 
We did not encounter any adverse events with respect to abnormal renal function relating 
to the use of the intravenous fluid and sodium restriction regime. Furthermore there were 
no readmissions during the pilot study and no complications were missed due to early 
patient discharge. The follow up arrangements trialed during this period appeared to work 
well and allowed for extra reassurance while the clinical team adjusted to the new 
discharge policy. The running of the pilot study also allowed us to identify a number of 
areas where practice needed to be changed prior to starting the main trial. 
 
Although the fluid restriction regime was instituted the results of the pilot study 
highlighted that patients in this group still received a median of 2.5 litres of fluid and 
246mmol of sodium. This was higher than levels targeted in the protocol and was mainly 
due to inexperienced medical staff inappropriately prescribing saline to study patients 
with low one hour urine volumes. In response to these difficulties we decided to increase 
the visibility of abbreviated versions of the study protocol both in the junior doctors’ 
room and in participating patients’ observation folders (See Appendix IV, V). Fluid 
charts were pre-printed with the restriction regime to alert doctors to patients’ inclusion in 
the trial (See Appendix VI). We also undertook training meetings with members of the 
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nursing staff and medical staff involved. The final alteration was to change to a policy of 
4 hourly urine volumes to avoid doctors responding to single hourly urine volumes. The 
levels of intravenous fluid and sodium infused on days one to three were felt to be in 
keeping with those desired for the trial. 
 
During the pilot study the hospital stay for patients in the fluid restriction group was 6 
days compared to 7.5 days in the control arm. The median hospital stay in the restricted 
group was comparable with the results of the Lobo trial (median 6 (i.q.r. 5-6) versus 6 (5-
7) days) however there were factors which suggested that even shorter hospital stays were 
achievable. The patients in the restricted group had a greater proportion of left sided 
resections which is likely to reduce the difference in hospital stay between the two 
groups. There were also 2 complications in the restricted group and one patient whose 
discharge was delayed due to social reasons. There were no complications in the control 
arm of the study. The median hospital stay of patients in the control arm was also shorter 
in our pilot study compared to the Lobo trail (7.5 (6-9) versus 9 (7.8-14.3) days). This is 
explained by the fact that many of the principles of fast-track surgery had already been 
adopted in the unit although they had not been formally described in a protocol. 
 
The running of the pilot study allowed us to confirm the safety of the fluid restriction 
regime prior to its application during the larger randomised trial. Data collection 
procedures including forms to be used during the study were trialed and refined during 
this period (See Appendix VII). Follow-up arrangements were formalized and both 
nursing and medical staff gained in experience with both the restricted fluid protocol and 
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fast-track recovery. The results suggested a faster return of gastrointestinal function as 
well as earlier discharge in the restricted fluid group. The results were not analysed 
statistically as the pilot study was not powered to look for significance between primary 
endpoints. 
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4.1 Introduction 
 
Use of intravenous fluids is an important part of perioperative management in patients 
undergoing elective or emergency surgery.  It is known from clinical trials that excess use 
of intravenous fluid can significantly increase weight and complications232-234.  More 
recently positive salt and water balance sufficient to cause a 3kg weight gain has been 
shown to delay return of gastrointestinal function and prolong hospital stay in patients 
undergoing elective colorectal resection232, 234.  Current opinion suggests that maintaining 
fluid balance such that the patient remains weight stable may reflect best practice in 
perioperative fluid management. 
 
Fast-track recovery programmes are becoming increasingly popular after major 
abdominal surgery257.  In order to achieve optimal fluid balance these programmes 
restrict the use of intravenous fluids intraoperatively and use little or no parenteral fluids 
after the first postoperative day145, 148, 241.  Patients are encouraged to drink protein drinks 
on the day of operation and resume normal food and oral liquids on day one 
postoperatively.  Following colonic resection very short hospital stays (2-3 days) have 
been reported with the use of epidural anaesthesia/ analgesia whereas length of stay has 
tended to be longer with patient-controlled analgesia (PCA : 4-6 days).  A recent 
randomised trial showed no benefit of thoracic epidural analgesia over PCA (length of 
stay 6 days in both groups) when used within a fast-track programme for patients 
undergoing colorectal resection258.  Whatever the precise components of ‘fast-track’ 
programmes they require an intensive multidisciplinary approach by surgeons, 
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anaesthesiologists, nutritionists and physiotherapists.  However the excellent results 
obtained by the enthusiasts have yet to be adopted widely.   
 
Previous studies have focused mainly on restricting fluids given during the intra-
operative period and have thus reduced total intravenous fluid load on the day of surgery 
from around 5-6 litres to about 2-3 litres233, 234.  Postoperative strategies have been less 
well defined and it has not been possible to separate the effect of intraoperative versus 
postoperative regimens. The aim of the present study was to investigate the effect of 
postoperative fluid restriction on recovery following elective colorectal surgery in 
patients managed with intraoperative fluid restriction.                                                                                
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4.2 Patients and methods 
 
Patients 
An observer blinded randomised trial was carried out between November 2003 and 
March 2005 with the approval of the relevant local Research Ethics Committee.   All 
surgeons involved in the trial have a specialist interest in colorectal surgery.  All patients 
undergoing elective colorectal resection with primary anastomosis were eligible unless 
they had significant renal impairment, suffering severe physical disability and in long-
term care, an insulin dependent diabetic or undergoing total colectomy, abdominoperineal 
resection of the rectum, or low anterior resection requiring a defunctioning stoma. 
Patients who were ineligible for the study were recorded to allow subsequent outcome 
analysis. 
 
Preoperative preparation 
Informed consent was obtained and patients were randomised postoperatively by 
automated telephone randomization to either restricted intravenous fluids or standard care 
(See Appendix I-III).  All patients were allowed free fluids and high calorie containing 
drinks for up to 2 hours before operation.  Patients did not receive bowel preparation 
except for those having left-sided surgery who received a phosphate enema the night 
before and the morning of surgery.  All patients received antibiotic and DVT prophylaxis. 
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Anaesthesia 
A standardized anaesthetic protocol was used and all patients received a restricted 
intraoperative fluid regime consisting of 4 per cent dextrose/ 0.18 per cent saline at 
10ml/kg/hr plus 3 x measured blood loss.  Normothermia was maintained throughout 
surgery and all operations were carried out through the smallest incision necessary to 
complete the procedure.   No nasogastric tubes or intra-abdominal drains were used. 
 
Analgesia 
PCA with morphine (1mg bolus, 5 minute lockout) was provided for 48 hours in both 
groups. Paracetamol (1g four times daily orally or rectally) was administered 
concurrently with Tramadol (50-100mg orally or intravenously) used for breakthrough 
pain.  NSAID use was withheld until the morphine PCA was discontinued.  Analgesia 
consumption for both groups was noted and visual analogue pain scores at rest and on 
movement were recorded twice daily. 
 
Diet and Fluids 
Oral fluids were encouraged immediately postoperatively in both groups with protein 
drinks (Fortisip® Nutricia Clinical, UK) and normal food introduced on day 1.  Patients 
in the sodium and water restricted group received 4 per cent dextrose/ 0.18 per cent saline 
intravenously at 83ml/hr giving them in total 2 litres of water and 60 mmol of sodium per 
day.  All intravenous fluids were stopped on day 1 in the restricted group unless there was 
a clinical reason to maintain them.  The control group received 1 litre 0.9 per cent saline 
and 2 litres 5 per cent dextrose per day intravenously, equivalent to 3 litres water and 154 
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mmol sodium per day, until day 3 unless decided otherwise by the consultant.  Patients in 
both groups had daily biochemistry, haematology and weight measurements between 
0800 and 0900 hours.   Nausea scores (0-4) were checked twice per day and antiemetic 
administration was recorded.  Time to first flatus and bowel motion was recorded for both 
groups.   All patients received chest physiotherapy and commenced active mobilization 
from the first postoperative day. 
 
Patient Discharge 
Decision on patient discharge was made by the consultant surgeon with responsibility for 
the patient who was blinded to the treatment group. This was achieved by covering the 
intravenous solution with an opaque bag while daily monitoring of events was undertaken 
by the consultant anaesthetist and surgical registrar. The consultant surgeon did not 
review the patient on the ward until the afternoon of day three, by which stage 
intravenous fluids were generally discontinued in both groups.  To be considered fit for 
discharge patients had to be apyrexial, fully mobile, passing flatus or faeces and using 
oral analgesics only for pain.  Discharge delayed by social problems was recorded as 
such. 
 
Complications 
All adverse events were recorded during the first 30 postoperative days with phone 
follow-up until review at clinic on day 14.  Patients were sent a Short Form 36 Health 
Questionnaire at three months259 (See Appendix VIII). Patients were also asked to state 
which study group they thought they had been randomised to (See Appendix IX). 
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Statistics 
Based on previous studies148, 232, 241 it was estimated that 80 randomised patients would 
give an 80% power to reject the null hypothesis that patients in the two groups had equal 
length of stay using a two-sided Wilcoxon rank sum test at a 5% significance level. Time 
to event data was compared between groups using log rank tests. Daily measurements of 
continuous outcomes were analysed by repeated measures linear regression analysis with 
auto correlated errors, allowing for random patient effects and a global intervention 
effect; daily intervention effects were estimated by inclusion of intervention × day 
interaction terms. Cumulative totals were compared between groups using bootstrap t-
tests. Data was analysed on an intention-to-treat basis. The statistical software package S-
Plus for Windows v 6.1® (Insightful Corporation, Switzerland) was used. 
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4.3 Results 
 
 
During the study period 97 eligible patients were identified.  Eighty patients gave their 
consent and were randomised (Figure 4.1).  The main reasons for non-randomization 
were renal impairment (8), anaesthetic cancellations (6) diabetes (2) and patient refusal 
(1).  The characteristics of the patients agreeing to randomization in both groups were 
similar at trial entry (Table 4.1). 
 
Fluid and Sodium Management: 
There were significant reductions in the amount of intravenous fluids administered to the 
restricted group on the day of surgery and for days 1,2 and 3 postoperatively (Table 4.2). 
Similar findings were observed for intravenous sodium although the difference was not 
significant by the third postoperative day. For each day of their hospital stay patients in 
the standard group were significantly heavier than those who had restricted intravenous 
fluids and sodium (p=0.002 – p<0.001) (Figure 4.2). 
 
Analgesia and Pain 
Patients in both groups used similar amounts of morphine, with a median of 69 (i.q.r. 32-
103) mg in the standard care group compared to 69 (41-80) mg in the restricted group ( 
mean difference 2.8 (95 per cent confidence interval -14.9, 20.8) mg; p=0.75).  No 
significant differences were found between groups in terms of other analgesics: 
Paracetamol (global p=0.93), Ibuprofen (p=0.94) and Tramadol (p=0.23). Pain scores at 
rest and on movement were similar in both groups throughout the patients’ hospital stay. 
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There were no significant global differences between groups in nausea scores. Similarly, 
there were no significant differences overall between groups in terms of antiemetic use. 
 
Biochemistry and Haematology 
There was marginal evidence of an overall difference in serum urea between groups 
(p=0.077), with a significant rise in the restricted group compared to the standard group 
from day 2 postoperatively (Table 4.3).  This was mirrored by increases in serum 
creatinine on days 1 and 2 postoperatively (p=0.065 and p=0.042, respectively). These 
changes were most likely due to the dilutional effect of excess fluid in the standard group 
and within the range of normal. No patient developed renal failure or suffered any 
adverse effect as a result of the biochemical changes.  There were no differences in the 
patients’ postoperative haemoglobin (global p=0.47), haematocrit (p=0.76) or albumin 
(p=0.43) between the groups. 
 
Patient Outcome 
There were no differences in the time to passage of first flatus (p=0.47) or bowel motion 
(p=0.80) between study groups (Table 4.4).  The time to which patients were considered 
fit for discharge and actual hospital discharge were also similar.  There were no 
differences observed in complications between the groups (p=0.31) although the study 
was not powered to this endpoint (Table 4.5). 1 patient in either group died 
postoperatively due to respiratory failure (1) and a staphylococcus septicaemia secondary 
to a central line insertion (1). Follow-up SF-36 scores also showed no difference between 
the groups in any of the components measured. 2 patients required readmission within 30 
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days of surgery. Of the 69 patients who returned the questionnaire regarding 
randomization 40 said they did not know which group they were in, 14 chose incorrectly 
and 15 chose correctly. This suggests that patients were effectively blind to the 
randomization. 
 
on-entrants 
Of the 17 patients who were not randomised into the trial during the study period follow-
up data was available for 12. The reasons for non-randomization were renal impairment 
(6), anaesthetic cancellations (4) diabetes (1) and patient refusal (1). Baseline 
characteristics for patients not included in the trial were similar to those randomised 
except for the proportion of patients having right sided surgery which was greater in the 
non-randomised group (Table 4.7). 
Patients who were not randomised to the trial received similar cumulative intravenous 
fluid volumes to patients in the standard arm of the trial although there was a trend 
toward higher cumulative intravenous sodium in the non-randomised patients (Table 4.8). 
Data on time to first bowel motion was not available for non-randomised patients. The 
median hospital stay for non-entrants was 8 (i.q.r. 6.8-18.0) days. 5 patients who were not 
randomised into the trial suffered complications: 3 patients developed anastomotic leaks 
all of which were treated by laparotomy and Hartmann’s procedure; 1 patient suffered a 
myocardial infarction postoperatively; 1 patient developed atrial fibrillation and 
pulmonary oedema. There were no deaths within 30-days of surgery. 
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Table 4.1 Baseline Characteristics for patients in the fluid and sodium 
restriction study 
 
 
 
 Standard Care Restricted 
N 41 39 
Age (years) 72.6 (67.3, 82.9) 73.2 (65.3, 78.0) 
Sex 
Male 17 (41%) 20 (51%) 
Female 24 (59%) 19 (49%) 
BMI (kg/m2) 25.8 (23.2, 28.7) 26.8 (22.5, 30.7) 
ASA Grade 
1 2 (5%) 2 (5%) 
2 26 (63%) 30 (77%) 
3 12 (29%) 7 (18%) 
4 1 (2%) 0 (0%) 
Operation 
Right hemicolectomy 12 (29%) 14 (36%) 
Left hemicolectomy 4 (10%) 3 (8%) 
Anterior resection 23 (56%) 19 (49%) 
Hartmann Closure 2 (5%) 3 (8%) 
Technique 
Laparoscopic 11 (27%) 11 (28%) 
Open 30 (73%) 28 (72%) 
Indication 
Benign 9 (22%) 9 (23%) 
Cancer 32 (78%) 30 (77%) 
Blood transfusion 3 (7%) 3 (8%) 
 
Values are median (interquartile range) for continuous or N (%) for categorical data 
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Table 4.2 Intravenous fluid and sodium daily quantities and cumulative 
totals for patients in the fluid and sodium restriction study 
 
 
 
  Standard Care Restricted Difference 
p-value 
  
Median 
(IQR) 
Median 
(IQR) 
Estimate 
(95% CI) 
Day of operation 
IV Fluids (l) 
2.75 
(2.50, 3.00) 
2.00 
(2.00, 2.62) 
-0.45 
(-0.76, -0.14) 
0.004 
Na+ (mmol) 
169 
(146, 266) 
122 
(60, 183) 
-78 
(-111, -46) 
<0.001 
Day 1 post-op 
IV Fluids (l) 
2.60 
(2.50, 3.00) 
2.00 
(2.00, 2.00) 
-0.58 
(-0.89, -0.27) 
<0.001 
Na+ (mmol) 
154 
(154, 231) 
60 
(60, 80) 
-83 
(-116, -50) 
<0.001 
Day 2 post-op 
IV Fluids (l) 
2.50 
(2.00, 3.00) 
0.00 
(0.00, 0.50) 
-1.75 
(-2.07, -1.44) 
<0.001 
Na+ (mmol) 
154 
(77, 216) 
0 
(0, 15) 
-126 
(-159, -94) 
<0.001 
Day 3 post-op 
IV Fluids (l) 
0.50 
(0.00, 1.50) 
0.00 
(0.00, 0.00) 
-0.56 
(-0.87, -0.25) 
<0.001 
Na+ (mmol) 
0 
(0, 77) 
0 
(0, 0) 
-23 
(-56, 9) 
0.16 
Cumulative total 
(incl. day 4 post-
op) 
IV Fluids (l) 
8.75 
(8.00, 9.80) 
4.50 
(4.00, 5.62) 
-3.39 
(-4.48, -2.20) 
<0.001 
Na+ (mmol) 
560 
(477, 667) 
229 
(131, 332) 
-316 
(-442, -197) 
<0.001 
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Table 4.3 Serum urea and creatinine for patients in the fluid and sodium 
restriction study 
 
 
 
  
Standard 
Care 
Restricted Difference 
p-
value 
  
Median 
(IQR) 
Median 
(IQR) 
Estimate 
(95% CI) 
Day of 
operation 
Serum urea 
(mmol/l) 
5.3 
(4.3, 6.9) 
5.5 
(4.5, 6.4) 
0.1 
(-1.3, 1.5) 
0.87 
Serum 
creatinine 
(mmol/l) 
89.0 
(77.0, 104.0) 
94.0 
(85.0, 107.0) 
6.6 
(-7.4, 20.6) 
0.36 
Day 1 post-op 
Serum urea 
(mmol/l) 
4.6 
(3.8, 6.0) 
5.3 
(4.2, 7.6) 
0.9 
(-0.4, 2.3) 
0.18 
Serum 
creatinine 
(mmol/l) 
88.5 
(79.8, 101.2) 
95.0 
(83.5, 116.0) 
13.0 
(-0.8, 26.8) 
0.065 
Day 2 post-op 
Serum urea 
(mmol/l) 
3.9 
(3.1, 5.1) 
5.4 
(3.9, 7.1) 
1.4 
(0.0, 2.7) 
0.046 
Serum 
creatinine 
(mmol/l) 
81.5 
(71.8, 90.0) 
89.0 
(77.5, 100.5) 
14.4 
(0.5, 28.2) 
0.042 
Day 3 post-op 
Serum urea 
(mmol/l) 
4.5 
(3.8, 5.8) 
5.7 
(4.8, 8.0) 
1.6 
(0.3, 3.0) 
0.020 
Serum 
creatinine 
(mmol/l) 
77.0 
(71.0, 93.0) 
90.0 
(77.0, 101.0) 
11.0 
(-2.9, 25.0) 
0.12 
Day 4 post-op 
Serum urea 
(mmol/l) 
5.2 
(4.2, 6.8) 
7.0 
(5.2, 8.7) 
1.5 
(0.1, 3.0) 
0.034 
Serum 
creatinine 
(mmol/l) 
79.5 
(68.2, 98.8) 
88.0 
(70.0, 97.0) 
8.8 
(-5.8, 23.5) 
0.24 
 
 
 
 
 125
Table 4.4 Times to study endpoints for patients in the fluid and sodium 
restriction study 
 
 
 
 
Standard Care Restricted HR (95% CI) p-value 
Time to first flatus 2.9 (2.4,3.3) 2.9 (2.3,3.8) 0.85(0.54,1.32) 0.47 
Time to first bowel 
movement 
4.9 (3.2,6.9) 4.7 (3.7,6.1) 1.06(0.68,1.65) 0.80 
Time to medical 
discharge 
5.9 (4.0,7.9) 5.8 (4.1,7.3) 0.97(0.62,1.53) 0.90 
Time to hospital 
discharge 
6.2 (5.0,10.1) 6.2 (5.0,9.9) 1.02(0.65,1.60) 0.92 
Total hospital stay 7.2 (6.1,11.2) 7.2 (6.1,11.0) 1.03 (0.66,1.61) 0.90 
 
Values are median (interquartile range) for times (in days) 
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Table 4.5  Complications for patients in the fluid and sodium restriction 
study 
 
 
 
 Standard (n=41) Restricted (n=39) 
Atrial fibrillation - 1 
Pulmonary oedema 1 - 
Myocardial infarct 1 1 
Respiratory failure 1 - 
Chest Infection - 1 
Wound infection 3 2 
Intra-abdominal sepsis - 1 
Central line sepsis - 1 
Wound dehiscence - 1 
Obstruction 1 - 
Prolonged ileus - 1 
Intra-abdominal bleed 1 1 
Upper GI bleed - 1 
*Acute renal failure - 1 
Rectovaginal fistula - 1 
Femoral nerve palsy 1 - 
Death within 30 days 1 1 
TOTAL 10 14 
 
Occurred following intra-abdominal bleed 
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Table 4.6 Mean Short Form 36 (SF-36) scores at 3 months after surgery 
for patients in the fluid and sodium restriction study 
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Table 4.7 Baseline Characteristics comparing non-randomised patients 
with patients randomised to the fluid and sodium restriction 
study 
 
 
 
 Study Non-entrants 
N 80 12 
Age (years) 72.8 (65.8, 81.0) 70 (63, 76) 
Sex 
Male 37 (46.2%) 5 (41.7%) 
Female 43 (53.8%) 7 (58.3%) 
ASA Grade 
1 4 (5%) 0 (0%) 
2 56 (70%) 11 (91.7%) 
3 19 (23.8%) 1 (8.3%) 
4 1 (1.2%) 0 (0%) 
Operation 
Right hemicolectomy 26 (32.5%) 5 (41.6%) 
Left hemicolectomy 7 (8.8%) 3 (25%) 
Anterior resection 42 (52.5%) 2 (16.7%) 
Hartmann Closure 5 (6.2%) 2 (16.7%) 
Technique 
Laparoscopic 22 (27.5%) 4 (33.3%) 
Open 58 (72.5%) 8 (66.7%) 
Indication 
Benign 18 (22.5%) 8 (66.7%) 
Cancer 62 (77.5%) 4 (33.3%) 
 
 
 
 
 
 
 
 129
Table 4.8 Intravenous fluid and sodium cumulative totals comparing non-
randomised patients with patients randomised to the fluid and 
sodium restriction study 
 
 
  Restricted Standard Care Non-entrants 
  Median (IQR) Median (IQR) Median (IQR) 
Cumulative 
total (day 0-3) 
IV Fluids (l) 
4.50 
(4.00, 5.62) 
8.75 
(8.00, 9.80) 
8.00 
(6.50, 10.75) 
Na+ (mmol) 
229 
(131, 332) 
560 
(477, 667) 
921 
(543, 1137) 
 
Values are median (interquartile range) for continuous or N (%) for categorical data 
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Figure 4.1 Trial profile for the fluid and sodium restriction study 
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Figure 4.2 Estimated mean daily weight change compared to baseline with 
95% CIs, for patients in the fluid and sodium restriction study 
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4.4 Discussion 
 
This study shows that with a conservative intraoperative fluid protocol, postoperative 
restriction of fluids and sodium has no significant effect on postoperative gastrointestinal 
function or hospital stay in patients undergoing elective colorectal surgery.   
 
When considering perioperative fluid management it is important to reach a balance 
between giving too little fluid with consequent hypovolaemia and organ dysfunction260  
or too much fluid with resultant oedema and a different array of organ dysfunctions232   
Goal-directed intraoperative fluid administration guided by an oesophageal doppler 
monitor has been suggested as one method to maintain optimal stroke volume and 
achieve an earlier return to bowel function and decrease in postoperative hospital stay238.  
Simply following a standard protocol which sets limits on fluid and sodium load (as in 
the present study) is an alternative approach which can be further adapted by the use of 
more invasive monitoring for the high-risk patient. 
 
The conservative intraoperative intravenous fluid and sodium regimen followed in the 
present study resulted in either group maintaining median body weight change within a 
kilogram of preoperative body weight on the first postoperative day.  This is in marked 
contrast to the ‘control’ arms of trials examining the effects of fluid management where 
patients have gained 3-6 kg in the immediate postoperative period233.  The lack of effect 
of the post-operative restriction regimen on clinical outcomes observed in the present 
study may be explained by the success of the intraoperative protocol in maintaining 
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weight-stability and avoiding such gross fluid gains.  Equally, although the unrestricted 
postoperative regimen adopted in the present study resulted in patients receiving 4 litres 
more fluid (and > 300 mmol more sodium) than the restricted group, the timing and rate 
of administration was such that the patients were able to excrete most of the fluid in a 
timely fashion. 
 
The factors that allow successful use of a restricted intraoperative fluid regimen include 
circumventing the patient coming to theatre in a dehydrated state by avoiding bowel 
preparation or excessive duration of preoperative fasting as undertaken in the present 
study.  Equally the avoidance of epidural anaesthesia/ analgesia may contribute to the 
level of control that can be exerted over excessive fluid administration.  Some centres use 
epidurals in ‘fast-track’ protocols and advocate the use of vasopressors or altered 
thresholds to manage epidural-related hypotension and thus avoid excessive fluid 
loading4.  However, in routine practice it may be difficult to avoid some degree of 
increased fluid administration.  By using a PCA-based regimen the present study avoided 
these issues which may have contributed to the ability to follow a relatively restricted 
fluid regimen in both arms of the protocol. 
 
Total hospital stay, including convalescence, for patients in this study was a median of 7 
days.  This is shorter than that observed in clinical trials of laparoscopic surgery208 but 
longer than that reported where accelerated discharge protocols have been used145, 148, 241.   
In a prospective study of 60 consecutive patients with similar co-morbidity to our 
population, Basse et al reported a median hospital stay of 2 postoperative days for 
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patients undergoing elective colorectal surgery241.  Similar results were obtained by 
Anderson et al in a randomised clinical trial comparing multimodal optimization and 
standard care148.  The readmission rate for patients in the Basse et al study was 15% while 
no patient in the Anderson study was re-admitted within 30 days of surgery.  While better 
pain control in the form of epidural analgesia could account for some of the difference in 
hospital stay between these studies and our trial, it is likely that use of different discharge 
criteria, for example, the patients’ ability to tolerate diet rather than waiting for the first 
bowel motion, may be more important in determining the length of hospital stay for the 
patient population146.  
 
The patients who were not randomised into the study had a longer hospital stay when 
compared with patients in the trial. This is unsurprising as the majority of patients were 
ineligible due to increased medical co-morbidity. The increased co-morbidity was not 
evident in patients’ ASA grade which was similar between the groups but is suggested by 
the increased rate of significant complications in the non-randomised group. 
 
It is clear from this and other studies that restriction of intravenous fluids intra and 
postoperatively is safe in well hydrated patients undergoing major elective abdominal 
surgery.  Further clinical trails are required to identify the components of fast-track 
surgery that significantly influence hospital stay including the indications for more 
invasive fluid balance monitoring. 
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CHAPTER 5 
 
EFFECT OF LAPAROSCOPIC COLOIC 
RESECTIO I FAST-TRACK PATIETS 
AFTER ELECTIVE SURGERY 
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5.1 Introduction 
 
Since the introduction of laparoscopic-assisted colorectal surgery over 10 years ago the 
technique has become increasingly popular. Data from randomised trials on outcomes 
following laparoscopic surgery has often lagged behind clinicians’ enthusiasm to adopt 
the technique. There are now a number of randomised trials in the literature which seem 
to confirm the improved results seen in early studies. While it does not appear that 
laparoscopic resection adversely affects the oncological outcome in colorectal cancer, a 
significant effect on short-term recovery has been widely reported207-210. Studies have 
shown that minimally-invasive surgery invokes a less pronounced inflammatory response 
and reduces the duration of ileus206, 210, 261, 262. It has also been shown that duration of 
hospital stay can be reduced to around 4-8 days compared with 6-11 days with open 
surgery204, 206-210, 212, 262. 
 
Over almost the same period that laparoscopic surgery has been gaining acceptance, 
interest has been growing in the area of enhanced perioperative recovery protocols. Such 
protocols involve a multi-disciplinary approach adopting evidence-based practice to 
reduce the surgical stress response and enhance recovery. Studies of fast-track recovery 
have reported hospital stays of 2-3 days following colorectal resection which is 
comparable to any of the best laparoscopic trials in the literature174, 213, 263. There is 
however little evidence comparing the effect of laparoscopic colorectal resection in fast-
track recovery patients. One recent study has suggested that there is no difference in 
terms of return of gastrointestinal function and duration of hospital stay in fast-track 
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patients randomised to open or laparoscopic colorectal resection174. This study has 
recently been challenged by another publication which suggests that hospital stay can be 
reduced by around 30% in fast-track patients using laparoscopic surgery211. 
 
The aim of our study was to investigate whether laparoscopic colorectal resection 
improved recovery with the use of a multimodal rehabilitation program. 
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5.2 Patients and methods 
 
We carried out a prospective audit between November 2003 and March 2005. Patients 
undergoing elective colorectal surgery with primary anastomosis at a University teaching 
hospital were included. Exclusion criteria included those with severe physical disability 
and in long term care, patients who were medically unfit for surgery and patients 
undergoing total colectomy, abdominoperineal resection or low anterior resection 
requiring a covering loop ileostomy. A decision on suitability for laparoscopic-assisted 
resection was made on a case by case basis by the operating surgeon. Both of the 
participating consultant surgeons carried out both open and laparoscopic procedures and 
were involved in all operations. A laparoscopic-assisted resection was defined as an 
operation where colonic mobilization and division of the vessels was performed 
laparoscopically. An extracorporeal anastomosis was fashioned for right sided lesions and 
an intracorporeal circular stapled anastomosis for sigmoid/ left sided lesions. Transverse, 
muscle splitting, single dermatome incisions were used for extraction of the specimen. 
The unit which is split over 2 sites has experience of around 50 laparoscopic colorectal 
procedures per annum and is a recognised centre for preceptorship. 
 
Patients were given preoperative information and allowed free fluids and high calorie 
containing drinks for up to 2 hours before operation. Patients undergoing right 
hemicolectomy did not receive bowel preparation while those having left sided surgery 
received a phosphate enema the night before and the morning of surgery. All patients 
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received antibiotic and DVT prophylaxis and no nasogastric tubes or abdominal drains 
were used. 
 
A standardized anaesthetic protocol was used with a conservative perioperative fluid 
regime consisting of 4 per cent dextrose/0.18 per cent saline at 10mls/kg/hr plus 3 times 
the measured blood loss. The postoperative analgesic regime was based around PCA 
Morphine which was continued for 48hours. Patients were also given regular Paracetamol 
with NSAIDs and Tramadol used for breakthrough pain. Oral fluids were pushed 
immediately postoperatively and normal diet was encouraged from day 1. Chest 
physiotherapy and active mobilization was also commenced on day 1. Urinary catheters 
were removed on day 2 unless there was a clinical reason for them to remain. 
 
We recorded patients’ weight, height, blood parameters, analgesic and antiemetic intake, 
visual analogue pain scores, nausea scores (0-4), time to first flatus and bowel motion and 
postoperative complications. Decision on patient discharge was made by the operating 
surgeon. To be considered fit for discharge patients had to be apyrexial, fully mobile, 
passing flatus or faeces, using oral analgesics only for pain, and have a healing wound. 
Following discharge patients were phoned daily by a research nurse until review at clinic 
on day 14. At 3 months patients were asked to complete the Short Form 36 health 
questionnaire. 
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Statistical analysis was carried out using the Mann Whitney U test or Fisher’s exact test 
where appropriate with measurements of continuous outcomes analyzed by repeated 
measures linear regression analysis. 
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5.3 Results 
 
During the study period 80 patients who satisfied the inclusion criteria underwent elective 
colorectal surgery with primary anastomosis. A fast-track recovery protocol was 
employed in all of these patients. 22 patients underwent laparoscopic assisted colonic 
resection and 58 had open surgery (Figure 5.1). Patients were well matched for 
demographic data including age, sex, BMI, ASA grade and surgical site (Table 5.1). 
 
Median incision size in the laparoscopic group was 9cm (i.q.r. 8-11cm) compared to 
21cm (17-24cm) in the open group. None of the patients in the laparoscopic group 
required conversion to an open procedure for colonic mobilisation. There was no 
significant difference in the use of morphine, with a median of 70mg (43-101mg) in the 
laparoscopic group compared to 67mg (33-91mg) in the open group (mean difference 4 
(95 per cent confidence interval -14.6, 23.9) mg; p=0.69). There was no difference 
between the groups in use of Paracetamol (global p=0.63) and Tramadol (p=0.96). 
Patients in the laparoscopic group used significantly more Ibuprofen (p=0.036). There 
was no difference in visual analogue pain scores at rest or on movement between the 2 
groups for the duration of their hospital stay (Figure 5.2).  
 
We did not see any difference in the use of antiemetics, namely Metoclopramide (global 
p=0.09), Prochlorperazine (p=0.24) and Ondansetron (p=0.28). Nausea scores also 
showed no significant difference (global p=0.39 (morning) and p=0.83 (evening)). 
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Time taken to passage of first flatus (p=0.36) and time to first bowel motion (p=0.07) was 
similar between the two groups. Time to medical discharge and time to actual hospital 
discharge was not significantly different between the 2 groups with the median day of 
discharge on the 5th postoperative day (Table 5.2). Two patients in the open group were 
readmitted following discharge. One patient was readmitted with a late wound dehiscence 
and a 96 year old patient was readmitted with diarrhoea. 
 
Postoperative complications were identified in 6 patients in the laparoscopic group and 
13 patients in the open group. There was no difference in infective (p=0.70) or non-
infective complications (p=0.73) between the 2 groups (Table 5.3). There were 2 deaths 
within 30 days of operation. One patient in the laparoscopic group died on day 1 from 
respiratory failure and another in the open group died on day 4 from a central line 
infection. There was no difference in short form 36 scores between the two groups for 
any of the components measured. 
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Table 5.1 Baseline Characteristics for patients in the laparoscopic/ open 
surgery study 
 
 
 
 Laparoscopic Open 
N 22 58 
Age (years) 72.0 (63.7, 78.8) 73.2 (66.8, 81.7) 
Sex 
Male 12 (54.5%) 25 (43.1%) 
Female 10 (45.5%) 33 (56.9%) 
BMI 25.1 (23.4, 28.8) 26.2 (22.4, 30.4) 
ASA Grade 
1 3 (13.6%) 1 (1.7%) 
2 14 (63.6%) 42 (72.4%) 
3 5 (22.7%) 14 (24.1%) 
4 0 (0.0%) 1 (1.7%) 
Operation 
Right hemicolectomy 6 (27.3%) 20 (34.5%) 
Left hemicolectomy 0 (0.0%) 7 (12.1%) 
Anterior resection 16 (72.7%) 26 (44.8%) 
Hartmann Closure 0 (0.0%) 5 (8.6%) 
Indication 
Benign 2 (9.1%) 16 (27.6%) 
Cancer 20 (90.9%) 42 (72.4%) 
 
Values are median (interquartile range) for continuous or N (%) for categorical data 
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Table 5.2 Times to study endpoints for patients in the laparoscopic/ open 
surgery study 
 
 
 
 Laparoscopic Open 
p-value 
 Median (IQR) Median (IQR) 
Time to first flatus 2.9 (2.3, 3.2) 2.9 (2.3, 3.6) 0.36 
Time to first bowel movement 5.3 (4.1, 6.2) 4.2 (3.1, 5.8) 0.07 
Time to medical discharge 5.8 (4.1, 7.8) 5.9 (4.1, 7.8) 0.99 
Time to hospital discharge 6.1 (5.0, 9.0) 6.2 (5.0, 10.0) 0.87 
 
Values are median (interquartile range) for times (in days) 
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Table 5.3  Complications for patients in the laparoscopic/ open surgery 
study 
 
 
 
 Open (n=58) Laparoscopic (n=22) 
Atrial fibrillation 1 - 
Pulmonary oedema 1 - 
Myocardial infarct 2 - 
Respiratory failure - 1 
Chest Infection - 1 
Wound infection 3 2 
Intra-abdominal sepsis 1 - 
Central line sepsis 1 - 
Wound dehiscence 1 - 
Obstruction 1 - 
Prolonged ileus - 1 
Intra-abdominal bleed 1 1 
Upper GI bleed 1 - 
*Acute renal failure - 1 
Rectovaginal fistula 1 - 
Femoral nerve palsy - 1 
Death within 30 days 1 1 
TOTAL 15 9 
 
*Occurred following intra-abdominal bleed 
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Figure 5.1 Trial profile for patients in the laparoscopic/ open surgery study 
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Figure 5.2 Estimated mean daily pain scores at rest and on moving, in the 
mornings or afternoons, with 95% CIs for patients in the 
laparoscopic/ open surgery study 
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5.4 Discussion 
 
Laparoscopic colorectal surgery has gained increasing acceptance over the past decade. 
The arguments made for adopting the technique in spite of higher costs, longer operating 
times and a steep initial learning curve have been based around the improvements in 
patient recovery. The perceived advantages of less postoperative pain and a reduction in 
ileus and length of hospital stay are felt to outweigh any such disadvantages. 
 
With the introduction of fast-track surgery dramatic improvements in perioperative care 
have been reported with hospital stays of between 2 and 3 days after open surgery174. 
While individual interventions have been validated by randomised clinical trials, their 
relative importance in the context of a multimodal rehabilitation program remains 
obscure.  
 
As in the study by Kehlet et al. we found no difference in pain scores or analgesic intake 
between the two groups174. These results are obviously quite different from previous large 
trials and meta-analyses of traditional care which have consistently shown an 
improvement in analgesia with laparoscopic surgery210. It may be that altering patients’ 
expectations preoperatively has a significant effect on their perception of pain. 
 
We also found no difference in duration of ileus or hospital stay with patients discharged 
on the 5th postoperative day. This is longer than in Kehlet’s group which may be due to 
the use of PCA morphine rather than epidural analgesia however a recent randomised 
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trial showed no benefit of thoracic epidural analgesia over PCA morphine when used in a 
fast-track program for patients undergoing colorectal resection258. The difference in 
hospital stay may also reflect the use of different discharge criteria by waiting for the 
passage of the first bowel motion but it is offset by fewer readmissions in the current 
study. The only study to show a difference in fast-track patients between open and 
laparoscopic surgery is the study by Kennedy et al. however this may be due to hospital 
stays of 7 days in the open group which is longer than those in the current trial211. While 
we did not see any difference between the groups in term of complications or quality of 
life when assessed at 3 months the study is not adequately powered for these specific 
endpoints. 
 
The number of patients in the current study is limited, as is the case with all the similar 
trials currently in the literature. While this series is non-randomised we would have 
expected any selection or observer bias to have benefited the laparoscopic group. We did 
not however see any significant difference in short term outcomes after colorectal surgery 
in fast-track patients treated laparoscopically. If laparoscopic resection does not improve 
short or long term outcomes then the significantly increased cost of the procedure may 
become difficult to justify212. 
 
We believe that with the introduction of multi-modal rehabilitation programmes, the 
benefits of laparoscopic-assisted colonic resection remain to be proven and that further 
large randomised trials are necessary to investigate the current controversy in the 
literature. 
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LIVER METASTASES 
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6.1 Introduction 
 
Liver resection is currently the recognised treatment for localised colorectal liver 
metastases. A large proportion of patients however will be unsuitable for resection either 
due to the extent of disease or their fitness for surgery. The prognosis without treatment is 
usually less than 12 months264, 265. Following liver resection the 5-year survival ranges 
between 30-50% with operative mortality of around 3%266-271. Recently published series 
of patients undergoing liver resection report hospital stays between 7-12 days269-272 for 
open surgery and 5-8 days273-276 for laparoscopic resection. 
 
As previously discussed there has been sustained interest recently in the use of ‘fast-
track’ recovery protocols in major abdominal surgery. Efforts have focused on 
attenuation of the surgical stress response and improving physiological function to reduce 
postoperative complications and hospital stay. Such protocols commonly include early 
mobilisation and diet, optimised fluid and analgesic regimens, as well as avoidance of 
abdominal drains and nasogastric tubes. With recent advances and growing experience in 
liver surgery it is well suited to the introduction of such protocols to further enhance 
postoperative recovery. 
 
As part of our clinical studies focusing on recovery following major abdominal surgery 
we were keen to introduce the principles of ‘fast-track’ recovery into our clinical practice. 
Multimodal rehabilitation has been applied to colorectal, orthopaedic, vascular and 
gynaecological procedures but has not previously been reported in liver surgery. By 
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comparing our results with data published in the medical literature, our aim was to 
measure the effect of a ‘fast-track’ recovery protocol on hospital stay following liver 
resection for colorectal metastases.  
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6.2 Patients and Methods 
 
Data was prospectively collected from 12 consecutive patients undergoing open liver 
resection for colorectal metastases between August 2003 and September 2004 in one 
surgical centre.  
 
All procedures were carried out by a single surgeon specialising in liver surgery. Patients 
were consented for surgery following a full discussion of the rehabilitation programme 
with both the patient and their family. All patients had open, segment-orientated liver 
resection carried out through a large sub-costal incision with full mobilisation of the liver. 
A standardised anaesthetic technique was used in all patients and normothermia was 
maintained throughout the procedure. Liver dissection was carried out with an ultrasonic 
dissector and Floseal® (Baxter International Inc. Deerfield, Illinois, USA) tissue glue 
was applied to the resection margins at the end of the procedure to aid haemostasis. 
Abdominal drains were not used in any patients following resection. Antibiotic 
prophylaxis consisted of a single dose of a cephalosporin administered intravenously at 
the beginning of the procedure.  
 
A multi-modal optimisation package was employed in all patients. Patients were allowed 
to drink clear fluids until 2 hours before surgery to avoid preoperative dehydration. Oral 
fluids were encouraged on the night of surgery with diet introduced on the first 
postoperative day if tolerated. Patients received supplement drinks twice daily until 
discharge. An intravenous fluid regime using 2 litres of 4% Dextrose/ 0.18% Saline was 
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administered over the first 24 hours unless signs of salt or water depletion became 
evident. A protocol using small boluses of Gelofusine was employed for patients with 
signs of hypovolaemia. Intravenous fluids were stopped after 24 hours.  
 
The analgesic regimen consisted of PCA Morphine for 24-48 hours with regular oral 
Paracetamol 1g four times daily. Following the cessation of PCA Morphine a non-
steroidal was commenced in the form of oral Ibuprofen 600mg four times daily. Where 
non-steroidal analgesia was contraindicated patients were commenced on Tramadol 50-
100mg four times daily. 
 
Urinary catheters were removed after 24-48 hours to aid mobilisation. Early mobilisation 
was encouraged and an intensive physiotherapy regime was employed. Blood samples 
were taken preoperatively, on the night of surgery and daily for the first 4 postoperative 
days. Decision regarding discharge from hospital was taken by the Consultant in charge 
of the patients care. Prior to discharge patients were required to be tolerating full diet, 
mobilising unaided and experiencing good analgesia with oral medication. Data on 
postoperative complications and hospital stay was recorded for each patient. Patients 
were seen in the outpatient clinic 2 weeks following their discharge. 
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6.3 Results 
 
12 patients with a median (i.q.r.) age of 60 (55-66) years underwent open liver resection 
for colorectal metastases. Resection consisted of 1 hepatic lobectomy, 2 
trisegmentectomy, 3 bisegmentectomies and 6 segmentectomies. Mean operating time 
was 130 minutes. Resection margins were clear in all patients (Table 6.1). 
 
All patients tolerated the early introduction of oral fluids and diet. The median time 
(i.q.r.) to cessation of intravenous fluids was the first postoperative day (1-2 days). 
Patients received a median volume of 3000mls (2500–4000mls) of intravenous fluid on 
the day of theatre, with 2000mls (1000–2500mls) and 500mls (0–1500mls) on days 1 and 
2 respectively. The median intravenous sodium load was 459mmols (343-496mmols), 
77mmols (45-154mmols) and 75mmols (0-87mmol) on day 0, day 1 and day 2 
respectively. One patient required a postoperative blood transfusion on the day of theatre. 
The median dose of morphine received was 12mg (5-23mg) on day 0, 16mg (4-23mg) on 
day 1 and 0mg (0-2mg) on day 2. 
 
Data on time to first bowel motion was available for 10 patients with a median time of 4 
(3-5) days to first bowel motion.  The median duration of hospital stay was 4 (3-5) days. 
 
1 epileptic patient developed carbamazepine toxicity following liver resection due to 
reduced enzymatic breakdown of the drug, delaying their discharge. A further 2 patients 
developed right upper quadrant fluid collections postoperatively requiring no 
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intervention. 1 patient was re-admitted with wound pain which settled after 48 hours with 
simple analgesia. There were no postoperative mortalities during the study period. We 
did not notice any significant alteration in renal function or in the recovery of synthetic 
liver function during the series (Table 6.2). 
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Table 6.1 Baseline Characteristics for patients in fast-track liver resection 
series 
 
 Liver resection 
N 12 
Age (years) 60 (55 - 66) 
Sex 
Male 8 
Female 4 
ASA Grade 
1 4 
2 7 
3 1 
4 0 
Mean operating time (mins) 130 
Operation 
1 Lobectomy 
2 Trisegmentectomy 
3 Bisegmentectomy 
6 Segmentectomy 
 
Values are median (interquartile range) 
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Table 6.2 Blood parameters for patients in fast-track liver resection series 
 
 
 
 Pre-op Day 1 Day 2 Day 3 
Hb 13.2 (12.3-13.9) 10.5 (10.1-12.4) 11.0 (9.1-11.7) 9.8 (8.8-10.9) 
Urea 4.5 (4.0-5.0) 5.5 (3.8-6.3) 4.0 (2.8-5.3) 4.2 (3.3-5.1) 
Cr 87 (74-100) 83 (68-93) 82 (63-101) 76 (59-100) 
Alb 44 (41-46) 32 (26-34) 33 (32-35) 35 (30-35) 
AST 23 (21-33) 354 (201-530) 233 (115-457) 122 (89-205) 
ALT 21 (16-22) 351 (204-579) 351 (178-918) 260 (149-628) 
Bil 11 (9-14) 17 (12-30) 22 (10-32) 23 (13-34) 
 
Values are median (interquartile range) 
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6.4 Discussion 
 
Liver resection is currently the treatment of choice for colorectal liver metastases. With 
increased experience in liver resection as well as recent technical advances, surgery is 
becoming safer for a larger proportion of patients266. Advances in postoperative care with 
the introduction of multi-modal rehabilitation programmes may offer a further benefit to 
those already being realised. The opportunity to get patients home quicker after surgery 
has implications not only for provision of healthcare services but also for a patient group 
where quality of life, and especially time spent out of hospital, is particularly important. 
 
Recovery protocols have already been used to good effect in other major abdominal 
procedures and liver surgery may also benefit from their introduction. Our short series of 
patients shows that rapid discharge from hospital following liver resection is both safe 
and achievable. Our results compare favourably to other series in the literature in terms of 
hospital stay, including laparoscopic series. It also compares favourably to historical 
controls with hospital stays of between 7 and 9 days prior to the introduction of fast-track 
recovery.  It is however only a small number of patients and caution must be used in 
comparing it to much larger series including more extensive resections. 
 
There have been a number of recent articles in the medical literature regarding the role of 
fluid and sodium restriction and the effects on postoperative recovery. In our series it was 
evident that patients tolerated the early introduction of oral fluids and diet. Furthermore 
the administration of intravenous fluid was limited to the first postoperative day.  While 
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we attempted to restrict the amount of intravenous fluid and sodium that patients received 
as part of the protocol it is evident from the volumes infused that this was only partly 
successful. On the day of operation patients received a median of 3L of fluid containing a 
median of 459mmol of sodium. This was more than the targets set out in the protocol but 
was less than the 5-6L of fluid often infused in this patient group during operation. We 
did not encounter any renal complications with the fluid regime employed. While we 
found than limiting intravenous fluid and sodium in the perioperative period was 
potentially achievable, this small series does not give further information regarding its 
efficacy. 
  
Further research is required to validate the individual elements of ‘fast-track’ protocols 
and the role of fluid optimisation and the effect on recovery in this particular patient 
group. There are also challenges brought about by the more rapid discharge of patients. 
From our initial experience with fast-track recovery it is clear that follow-up 
arrangements and access to surgical services have to be closely considered to ensure that 
patient care is not sacrificed in the drive for ever quicker turnover.  
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CHAPTER 7 
 
THE EFFECT OF COLOIC RESECTIO 
O RECOVERY OF 
GASTROITESTIAL FUCTIO 
FOLLOWIG MAJOR ABDOMIAL 
SURGERY 
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7.1 Introduction 
 
The first mention of postoperative ileus as a clinical entity was by Pal in 1890151. Ileus 
can be described as ‘the transient impairment of bowel motility after abdominal surgery 
or other injury277. It is a significant cause of postoperative morbidity, causing nausea, 
vomiting and abdominal pain as well as delaying the institution of oral diet, early 
mobilisation and ultimately discharge from hospital. The causes of ileus have again come 
under scrutiny in the medical literature with the introduction of fast-track surgery as ileus 
is one of the main barriers in colorectal surgery to discharging patients early. 
 
The pathophysiology of ileus is multifactorial although the relative influence of 
individual factors as well as their hierarchical order is still a matter for debate. Inhibitory 
reflex arcs with afferents from somatic, visceral and parietal fibres are thought to play a 
part. Important also is the interplay between the sympathetic and parasympathetic 
nervous system as well as the intrinsic nervous system of the gastrointestinal tract. The 
parietal peritoneum has been shown to play a major role in the process with inflammatory 
mediators, endogenous and exogenous opioids also exerting an influence. 
 
Studies into extent, location and duration of ileus have been largely contradictory. We do 
know from both animal and human studies that ileus resolves quickly in the stomach and 
small intestine but that the left colon is the most functionally depressed and contributes 
significantly to duration of postoperative ileus137, 138, 152, 278. It is also clear from studying 
the return of myoelectrical activity to the left colon following surgery that there is good 
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correlation between the resolution of ileus and the passage of the first bowel motion 
which is used as a clinical endpoint137. 
 
It has been a traditionally held view that intestinal manipulation and operation time have 
a significant effect on the duration of postoperative ileus. However there has been little 
evidence to support this. A number of in vitro studies have proposed a local inflammatory 
role154-159. It has been suggested that the trauma provoked by handling of the bowel 
causes an increased inflammatory cell infiltrate in the muscular layer along with an 
increase in mucosal permeability. This local inflammation may interfere with 
myoelectrical activity causing postoperative ileus. It is also claimed that the increased 
mucosal permeability leads to bacterial translocation and further postoperative morbidity. 
While these experimental findings seem to support the traditional surgical viewpoint they 
have not been supported by clinical studies in humans. It has already been shown that the 
left colon is the rate limiting step in the resolution of gastrointestinal function. The 
studies suggesting a local inflammatory process induced by manipulation were carried 
out on animal small bowel which may explain the conflicting results. 
 
Controversy over the effect of intestinal manipulation during surgery still remains and 
linked to this the effect of the colonic resection itself on the return of gastrointestinal 
function has not been widely researched. The aim of this study was to investigate the 
effect of intestinal manipulation and colonic resection on the return of gastrointestinal 
function following major abdominal surgery.  
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7.2 Patients and Methods 
 
We carried out a prospective study of 10 consecutive patients undergoing colorectal 
resection and 10 consecutive patients undergoing liver resection in one surgical centre 
and operated on by a single surgeon. In this way we compared 2 groups of patients each 
undergoing major abdominal surgery, one with colonic resection and mobilisation, the 
other with minimal gastrointestinal manipulation and no colonic resection. Liver 
resections were carried out through a large right sub-costal incision with full mobilisation 
of the liver. Colonic resections were carried out through a mid-line laparotomy. In both 
groups an identical recovery protocol was instituted. 
 
As part of the recovery protocol no nasogastric tubes or abdominal drains were used. 
Early oral feeding was offered to all patients consisting of oral fluids immediately after 
surgery and light diet from the morning after surgery. Due to the lack of ward facilities 
available to manage epidurals the postoperative analgesic regime was based around PCA 
morphine. Patients were also prescribed regular non-opioid analgesics in the form of 
Ibuprofen and Paracetamol to try to minimise opioid use. All other medications with an 
effect on gastrointestinal motility were stopped prior to surgery. All patients were 
managed with a restricted intravenous fluid regimen aiming at 2 litres of intravenous fluid 
over the first 24 hours alone. The intravenous fluid used was 4% dextrose/ 0.18% saline 
to deliver the recommended daily requirement of sodium. Patients underwent an intensive 
physiotherapy regime to encourage early mobilisation. 
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Data was collected on sodium and fluid intake, opioid intake, blood parameters, time to 
first bowel movement and hospital stay. Results were analysed with Student's t test. A P-
value less than 0.05 was considered to be statistically significant. 
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7.3 Results 
 
The median (i.q.r.) age of patients undergoing colorectal resection was 73 years (67-77) 
compared with a median age of 61 years (56-66 years) for patients undergoing liver 
resection. The male to female ratio, ASA grades and mean operating time between the 
two groups were not significantly different (Table 7.1). 
 
The colonic resection group required significantly more opioid analgesia on the first 
postoperative day with 31mg (7-42mg) versus 16mg (5-28mg) (p=0.01). There were no 
significant differences in the use of other analgesics during the postoperative period. The 
liver resection group received significantly more intravenous fluid on the day of theatre 
with a median of 3 (2.5-4) litres versus 2 (2-2.2) litres (p<0.01) (Table 7.2).  
 
Despite the intravenous fluid restriction regime and use of non-steroidal anti-
inflammatory analgesics we did not encounter any adverse effect on renal function. Liver 
transaminases were raised postoperatively in the group undergoing liver resection but 
quickly returned to normal levels. 2 patients undergoing liver resection required a 
postoperative blood transfusion compared with no patients undergoing colonic resection 
(Table 7.3). 
 
The median time to first bowel motion for patients undergoing colorectal resection was 
4.5 (4-5) days compared with 4 (3-5) days for patients undergoing liver resection 
(p=0.22). The median hospital stay was 4.5 (4-6) days for patients undergoing colorectal 
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resection compared with 4 (3-6) days for patients undergoing liver resection (p=0.43) 
(Figure 7.1).  
 
2 patients undergoing liver resection developed small postoperative fluid collections 
which did not require treatment. 1 liver resection patient was re-admitted on 
postoperative day 7 with wound pain which settled with analgesia. There were no 
complications in the colonic resection group. 
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Table 7.1 Baseline Characteristics for patients undergoing colonic/ liver 
resection 
 
 
 
 Colon resection Liver resection 
N 10 10 
Age (years) 74 (61 - 83) 61 (56 - 66) 
Sex 
Male 5 6 
Female 5  4 
ASA Grade 
1 1 3 
2 7 6 
3 2 1 
4 0 0 
Mean operating time (mins) 120 130 
Operation 
5 Right Hemicolectomy 
1 Lobectomy 
1 Trisegmentectomy 
5 Left Hemicolectomy 
3 Bisegmentectomy 
5 Segmentectomy 
 
Values are median (interquartile range) 
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Table 7.2 Opioid and intravenous fluid intake for colon/ liver resection 
patients  
 
 
 
 
Colon resection 
(n=10) 
Liver resection 
(n=10) 
 
Morphine Day 0 (mg) 31 (7-42) 16 (5-28) P=0.01 
Morphine Day 1 (mg) 31 (21-43) 21 (9-34) P=0.13 
IV Fluid Day 0 (mls) 2000 (2000-2200) 3000 (2500-4000) P<0.01 
IV Fluid Day 1 (mls) 2000 (1500-2000) 2250 (1000-2500) P=0.36 
 
Values are median (interquartile range) 
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Table 7.3 Blood parameters for patients undergoing colonic/ liver 
resection 
 
 
 
 
Values are median (interquartile range) 
 
 
Colon patients Pre-op Day 1 Day 2 Day 3 
Hb 12.3 (11.3-13.5) 12.3 (11.6-13.1) 11.5 (10.2-11.8) 11.8 (10.3-12.7) 
Urea 5.4 (4.7-7.2) 5.2 (4.7-6.9) 5.5 (3.8-7.1) 5.0 (4.1-8.8) 
Cr 97 (87-108) 91 (85-129) 93 (86-110) 97 (92-105) 
Alb 42 (41-43) 37 (36-39) 36 (36-38) 36 (34-41) 
Liver Patients Pre-op Day 1 Day 2 Day 3 
Hb 13.2 (12.3-13.9) 10.5 (10.1-12.4) 11.0 (9.1-11.7) 9.8 (8.8-10.9) 
Urea 4.5 (4.0-5.0) 5.5 (3.8-6.3) 4.0 (2.8-5.3) 4.2 (3.3-5.1) 
Cr 87 (74-100) 83 (68-93) 82 (63-101) 76 (59-100) 
Alb 44 (41-46) 32 (26-34) 33 (32-35) 35 (30-35) 
AST 23 (21-33) 354 (201-530) 233 (115-457) 122 (89-205) 
ALT 21 (16-22) 351 (204-579) 351 (178-918) 260 (149-628) 
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Figure 7.1 Time to return of gastrointestinal function: boxes show median 
and interquartile range; whiskers give range by study group for 
patients undergoing colon/ liver resection 
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7.4 Discussion 
 
The results of the study suggest that the colonic resection itself has little effect on the 
duration of ileus after major abdominal surgery. The colonic resection group did receive 
significantly more opioid analgesia postoperatively which should have had the effect of 
delaying the return of gastrointestinal function in this group. We would have expected 
this to exaggerate the difference between the groups however this was not borne out by 
our results. The liver resection group received more intravenous fluid in the postoperative 
period but the effect that this may have had on duration of ileus is not yet clear from 
clinical trials. It is also worth noting that all of the liver patients had undergone previous 
colectomy for removal of the primary tumour. We could have expected this to reduce 
transit times and possibly exaggerate the difference between the groups but this was not 
borne out by the results. 
It is difficult to identify the perfect control group for the comparison of colonic resection 
in a clinical setting. There may be inherent differences between the two groups that we 
are unaware of which may affect the duration of ileus. However we did not see any 
clinically relevant difference relating to colonic resection and the return of 
gastrointestinal function. 
While the number of patients in the study is small the results would be in line with 
previous animal studies relating to the site and extent of operative dissection and the 
duration of postoperative ileus137, 138, 152, 278. Our results would however contradict in vitro 
studies suggesting impairment of muscle function from leucocytic infiltration secondary 
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to manipulation of the bowel154, 156. Larger studies would be required to further validate 
the results of our study. 
The study also demonstrates the effects of a fast-track protocol on recovery and hospital 
stay following major abdominal surgery. In both the liver resection and the colonic 
resection patients, median discharge was on the fourth postoperative day with only 1 
subsequent readmission. 
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CHAPTER 8 
 
COCLUSIOS 
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Some of the major recent advances in the development of modern surgery have been 
concerned with perioperative care and recovery of the patient following surgery. Interest 
in recovery has focused on both the efficacy of individual interventions as well as 
processes and pathways to improve outcome. Improvements in perioperative recovery 
have allowed for many surgical procedures to be carried out on an outpatient or ‘day-
surgery’ basis which in the past would have required an in-patient stay. This has benefits 
not only for the patient who has a faster recovery but for healthcare systems and society 
in general as costly inpatient beds are reduced and patients return to work more quickly. 
As experience has grown in this area the principles of rapid recovery have been applied to 
an increasing number of procedures. It is on this background that the idea of ‘fast-track’ 
surgery has become popular over the last decade. 
 
Fast-track surgery refers to an approach proposed by Professor Henrik Kehlet. The idea is 
that through a multidisciplinary, protocol-driven approach and using evidence-based 
recovery techniques the stress response to surgery can be modified to reduce end-organ 
dysfunction and promote a more rapid recovery. Using such an approach Kehlet’s group 
have reported hospital stay following colorectal resection of around 2-3 days174, 213, 263. 
Further applying his ideas to orthopaedic279, gynaecological253 and vascular surgery252, 
similar improvements in recovery have been suggested. These initial findings have so far 
been limited to case series carried out by enthusiasts and have not been widely adopted 
into clinical practice. They have also drawn criticism regarding the safety of such rapid 
discharge from hospital and the burden placed on primary care and the wider community. 
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To investigate the effects of both individual interventions and the use of fast-track 
recovery protocols we carried out a review of the recent medical literature. Following this 
we were able to draw certain conclusions regarding the efficacy of different aspects of 
perioperative clinical practice. In particular we focused on recovery following major 
abdominal surgery including colorectal resection. It is clear from reviewing the evidence 
that many of the interventions that are still made are based on traditions of care passed on 
through an apprenticeship model of training with little basis in clinical science.  
 
The use of nasogastric tubes has until recently been routine practice suggested to reduce 
postoperative ileus, nausea and vomiting. It has also been claimed to reduce aspiration, 
wound dehiscence and anastomotic leakage. There is however no evidence to support 
these claims with significant patient discomfort and increased respiratory complications a 
likely side-effect. The use of nasogastric tubes also delays the introduction of oral diet.  
 
Providing oral diet for patients after gastrointestinal surgery is another area where 
practice is slowly changing. It is now clear from the literature that the majority of patients 
will tolerate diet and oral fluids immediately after surgery with no detrimental effects. 
Concerns over disruption of anastomoses or an increased incidence of aspiration have not 
been borne out although improvements in overall outcome have been difficult to prove. 
 
Intra-peritoneal drains date back to the very earliest pioneers of surgery and for almost as 
long there has been controversy over their use. Placing drains after elective gastro-
intestinal surgery is not supported by current evidence. The drain is rapidly encapsulated 
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and does not drain the general peritoneal cavity, provoking its own foreign body response 
and serous exudate. Furthermore, there is no evidence to suggest that drains reduce or 
control the effect of an anastomotic leak. 
 
Mechanical bowel preparation is yet another area that has been steeped in surgical 
dogma. Its use dates to around the Second World War when surgeons recognised that 
infective complications following gastrointestinal surgery were common due to the high 
bacterial count of colonic content. Since its widespread acceptance into clinical practice 
there have been a number of important developments not least the overwhelming 
evidence for antibiotic prophylaxis in colorectal surgery. Despite this the efficacy of 
bowel preparation has not been fully re-examined. The evidence that is available suggests 
that at the very least there is no difference in complication rate when avoiding the use of 
bowel preparation and this approach may even carry a reduced rate of anastomotic 
leakage. 
 
With a change in practice away from the use of nasogastric tubes and toward early 
feeding of patients postoperatively, the problem of postoperative ileus has come under 
close scrutiny. Ileus has a multifactorial pathophysiology and is not clearly understood. It 
is also a major source of morbidity following abdominal surgery. Many factors 
influencing the duration of ileus have been investigated including the extent, location and 
duration of surgery, the effect of minimally invasive surgery and also opioid analgesics 
and other pharmacological agents. Up to this point the most significant single 
intervention has been that of thoracic epidural analgesia which is thought to work by 
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blocking the spinal reflex arc partly responsible for the delay in return of gastrointestinal 
function. These results have led to thoracic epidural analgesia becoming the gold standard 
for elective colorectal surgery and allowing opioid sparing with further benefits in terms 
of reducing postoperative ileus. 
 
During the course of our scientific work ileus has been a significant focus. We 
investigated further the effect of bowel manipulation and resection by comparing a group 
of patients undergoing colonic resection and a group of patients undergoing liver 
resection. The patients in the liver resection group had no bowel handling during major 
abdominal surgery of similar duration to the colonic group. The same recovery pathway 
was used in each group. We found no difference in the duration of ileus between the two 
groups (median 4.5 (i.q.r. 4-5) versus 4 (3-5) days) suggesting that bowel handling and 
the act of colonic resection have little clinically relevant effect on the duration of ileus. 
 
The use of minimally invasive techniques or laparoscopic surgery is an increasingly 
popular topic within abdominal surgery. After a rapid early uptake of the technique in the 
early 1990’s it fell out of favour after reports of compromise to the oncological clearance 
of colorectal cancer. It has taken over a decade to recover and now its equivalence to 
open surgery in terms of oncological outcome is in little doubt. The advantages proposed 
for laparoscopic surgery have been based on more rapid short-term recovery and reduced 
postoperative complications. While improvements in recovery have certainly been proven 
it is not clear whether these relate to the technique itself or to the differences in recovery 
pathways used postoperatively. Laparoscopic surgeons have tended to be among the more 
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progressive encouraging early feeding and mobilisation and it may be this that has led to 
the reductions in hospital stay. It has been suggested that applying the same recovery 
pathways to open surgery in the form of ‘fast-track’ surgery can lead to comparable 
results. 
 
To investigate this further we studied a prospective group of patients undergoing elective 
colorectal resection using either open or laparoscopic-assisted surgery. We applied the 
same fast-track recovery protocol to both groups of patients. We found that when patients 
were aggressively rehabilitated there was no difference in pain (global p=0.24-0.74), 
return of gastrointestinal function (median 5.3 (i.q.r. 4.1-6.2) versus 4.2 (3.1, 5.8) days; 
p=0.70) or hospital stay (5.8 (4.1-7.8) versus 5.9 (4.1-7.8) days; p=0.99) between the two 
groups. There were no obvious differences in postoperative complications although the 
study was not powered to look at this endpoint. The study suggests that before 
laparoscopic surgery is introduced more widely there needs to be further research carried 
out to define the potential advantages. The technique is significantly more expensive than 
open surgery therefore unless there are benefits with respect to long-term complications 
its cost-effectiveness remains in doubt. 
 
It is clear that a number of areas regarding laparoscopic surgery and the effect on 
recovery require further study. While certain procedures can be carried out entirely 
laparoscopically others such as colorectal resection require a limited laparotomy either 
for the purposes of anastomosis or specimen retrieval (laparoscopically-assisted). The 
overall effect of incision size on recovery following abdominal surgery has never been 
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clearly defined. With the introduction of laparoscopic cholecystectomy the benefits in 
terms of reduced analgesic requirement, hospital stay and convalescence were clear when 
compared with conventional cholecystectomy280. However when compared with mini-
laparotomy cholecystectomy through a 6cm incision the benefits in short-term recovery 
disappear281, 282, 115. Colorectal resection can feasibly be carried out through incisions 
comparable to the size of retrieval wounds used during laparoscopically-assisted 
procedures283. It may be that below a critical incision length there is little difference in 
recovery between open and laparoscopic surgery. Further randomised trials in this area 
are required to clearly define the role of incision length in postoperative recovery. 
 
Following on from the perceived benefits of laparoscopic surgery is the introduction of 
the idea of “no scar surgery”. With the advances in flexible endoscopy there has been 
interest in the feasibility of natural orifice trans-luminal endoscopic surgery (N.O.T.E.S.). 
This new concept involves gaining access to the peritoneal cavity via a transgastric, 
transcolonic, transvesical or transvaginal route by creating an intentional perforation. The 
theoretical advantages of this approach include reduced abdominal wall pain due to the 
absence of an incision, with a reduction in wound infection, hernia formation and 
adhesions. Until recently experiments have been limited to the animal model. A wide 
variety of procedures have been reported from liver biopsy and cholecystectomy to 
splenectomy and gastrojejunostomy284-287. The first human procedure was reported by 
Rao and Reddy in India who carried out a transgastric appendicectomy on a patient with 
severe abdominal wall burns (oral/ video confirmation only). This was followed in April 
2007 by a cholecystectomy via the transvaginal route carried out in Strasbourg by 
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Professor Marescaux. While in an early stage of its development a number of technical 
challenges have arisen including closure techniques, instrument limitations, methods of 
retraction and dealing with complications. There is also little evidence thus far as to 
whether the theoretical benefits in terms of recovery and morbidity will actually be 
realised. Further trials in this exciting area will be required before the role of natural 
orifice surgery can be determined. 
 
The use of intravenous fluids during the perioperative period is commonplace but despite 
this, evidence regarding its effect on patient recovery has been limited. In 2002 Lobo et 
al. published a trial in the Lancet suggesting that following a regime of restricted 
intravenous fluid and sodium could reduce both duration of ileus and hospital stay232. The 
study suffered from limited numbers and the lack of blinding and so we decided to carry 
out a large randomised controlled trial to test the hypothesis. Our findings suggest that 
using a restricted intraoperative fluid protocol, postoperative fluid and sodium restriction 
has no effect on return of gastrointestinal function or hospital stay. There is apparent 
contradiction between the findings of our trial and the Lobo trial however on closer 
examination of the results clear conclusions can be reached. Following the Lobo trial and 
a further study by Brandstrup233 reporting reduced complications with a restricted fluid 
regime it was felt unethical to use the volumes of intravenous fluid reported in these 
studies. The previous studies had given up to 6 litres of fluid on the day of theatre which 
at the time was not excessive when compared with retrospective reviews of practice. This 
large difference in fluid volumes is the likely reason for the differences seen in 
postoperative outcome. Despite a large cumulative difference in intravenous fluid and 
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sodium in our trial we limited the control arm to around 3 litres of fluid on the day of 
operation. By comparing the results from the three trials it is clear that the most important 
period for fluid balance is the immediate perioperative phase, at the height of the 
metabolic-endocrine response. During the first 24 hours the body retains any excess fluid 
causing tissue oedema, which can lead to increased complications, duration of ileus and 
in turn hospital stay. After the immediate perioperative phase the body’s own homeostatic 
mechanisms are more able to cope with any fluid excess. 
 
The wider interest in fluid therapy around the time of surgery has increased over the 
period of our studies. New techniques have developed particularly relating to the 
monitoring of fluids and intravascular volume. Studies regarding the use of oesophageal 
Doppler monitoring suggest that particularly where large fluid shifts are likely or 
significant co-morbidity is present that goal-directed therapy may improve outcome237-239. 
Even newer techniques are now available allowing cardiac output to be measured from a 
peripheral arterial-line catheter. This will mean that guided therapy will be possible in 
awake patients during the postoperative period rather than solely ventilated patients 
(Lithium Dilution Cardiac Output (LiDCO monitors)). Further studies are required to 
determine the effect of goal-directed fluids on recovery and whether it is beneficial when 
compared to a protocol-driven approach such as the one used in the present study. The 
role of new technology will also require additional research to compare different types of 
monitoring, which patients derive most benefit and the duration for which monitoring is 
required. 
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While much of the recent interest has focussed on the volume of intravenous fluid 
administered in the perioperative period, conclusions can also be reached about the 
optimal type of fluid. Evidence suggests that large volume administration of salt 
containing fluids, particularly normal saline, may be detrimental to patient recovery. 
Balanced fluids such as Hartmann’s solution reduce the incidence of hyperchloraemic 
acidosis and the resulting reduction in gastric mucosal perfusion when compared to 
saline-based fluids225. Hyperchloraemia has also been shown to lead to reduced renal 
blood flow and increased nausea, vomiting and abdominal pain 223, 225, 288.  
 
While it is true that crystalloid and sodium restriction does seem to improve postoperative 
outcome, some of the benefit attributed to the approach may be due to the difference in 
the relative administration of colloid. This is particularly clear in the goal-directed fluid 
trials where patients in the monitored arm received early administration of approximately 
500mls of extra colloid compared to the control group. It may be that as suggested in our 
own trial the timing as well as type of fluid is important for recovery. Even in the trials of 
crystalloid restriction, colloids were used predominantly to treat clinically apparent 
hypovolaemia and this may have had an influence on patient outcome. Further 
randomised trials will be required to determine the relative importance of these different 
facets. Current advice should include the use of balanced fluids, relative crystalloid 
restriction for maintenance requirements and the early use of colloids guided where 
possible by monitoring of secondary circulatory variables.  
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While we have concentrated on certain individual interventions during the period of study 
we have also gained in experience using fast-track recovery techniques. By applying fast-
track principles to an area of surgery where it has not previously been reported we were 
able to show significant reductions in hospital stay following liver resection when 
compared to data in the medical literature. We looked at patients undergoing elective 
colorectal resection both before and during the running of the randomised controlled trial 
and found that in our practice the recovery protocol used led to a reduction in 
postoperative stay of around 2 days (5.8 (4.1-7.8) versus 7.5 (6.0-9.0) days). This has 
significant implications both for patients and for healthcare systems. While the length of 
stay for patients in our trial is longer than that reported by Kehlet’s group (day 3 versus 5) 
we did not find the high rates of re-admission experienced in their practice. We found the 
technique to be safe with no adverse effects directly attributable to rapid discharge. 
 
Advances in postoperative recovery continue to make surgery safer for the majority of 
patients. Recovery protocols draw together evidence-based practice applying individual 
interventions for a synergistic effect. Further research is necessary particularly in the 
areas of intravenous fluid management and minimally invasive surgery so that these 
benefits can be realised still further.  
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APPEDIX I 
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APPEDIX I (continued) 
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APPEDIX II 
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APPEDIX III 
 
Fluid Optimisation Study worksheet:  
Randomisation 
 
step IVR System action data instructions 
1 Call Fluid Optimisation Study randomisation system 
“Welcome to the fluid optimisation study randomisation system” 
Dial Fluid Optimisation Study 
IVR telephone number. 
2 “Please enter your Centre number”           
Enter the 3-digit centre number 
that you have been assigned. 
 The centre number will be checked for validity. If the centre number does not exist an error 
message will result: “The centre number you entered was not recognised, please try again” and 
step 2 will be repeated. 
 
3 “Please enter your PI"”                 
Enter your 5-digit personal 
identification number (PIN). 
 Your PIN will be checked for validity with two possible invalid outcomes.  
• The PIN does not exist in the system. Error message “The PI" you entered was not 
recognised” will play and you will be sent back to the start of step 3. 
• The PIN is valid but the combination of PIN and centre number do not match a valid user 
of the IVR system. Error message “The PI" you entered is not valid for the center 
number given” will play and you will be sent back to step 2. 
 
4 Main menu 
“…to randomise subjects press 2…” 
 2  
Press 2. 
 Randomisation node pathway selected.  
5 Randomisation 
“Please enter the patient number that you want 
to randomise" 
                   
Enter the 6-digit patient number 
(including leading zeroes) of a 
patient to randomise. 
 • If an invalid patient number is entered the error message “You entered an invalid patient 
number, please try again” will play and you will be sent back to the start of step 5. 
• If the patient number has already been randomised the message “Patient ###### has 
already been randomised. Thank you for calling, goodbye” will play and the call will end. 
• Patient not randomised – OK to proceed with randomisation, move to step 6. 
 
6 “Patient ###### is about to be randomised. To proceed with 
randomisation press 1, press 2 to re-enter the patient or 
press 3 to end the call.” 
 1  
Press 1 to randomise the patient 
number entered, press 2 to 
return to step 5 to enter the 
patient number again or press 3 
to end the call. 
 • If 2 was selected then you will return to step 5 to allow the patient number to be re-
entered. 
• If 3 was selected then you will hear the message “Thank you for calling, goodbye” and 
the call will be ended. 
• If you press 1 then the system will attempt to randomise the patient. 
 
 • The system will try to randomise the patient and assign and treatment type. 
• An error in the randomisation process will result in the message “There are no 
randomisation numbers remaining for your centre. You may have to contact a study 
administrator” being played. The call will then end. 
 
10a If randomisation was successful: 
“You have been assigned treatment type Restricted fluid      
   Standard care     ” 
Write down the treatment type 
assigned to the patient. 
10b “To hear this value again press 1 or press 2 to exit the 
system” 
 2  
… or press 1 to hear the value in 
10a repeated again. 
11 “Thank you for calling, goodbye”  
 
 
 
 
Signed ___________________  Date ___________ 
 189
APPEDIX IV 
 
FLUID RESTRICTIO STUDY PATIET 
 
AME   ................................................................................ 
 
RESTRICTED    STADARD   
 
 
PRE-OP: Allow diet until 6 hours pre-op 
   Encourage clear fluids until 2 hours pre-op 
 
FLUIDS: Restricted - 2 L 4% Dextrose/ 0.18% Saline daily 
- Stop IV fluids after 24hrs 
 
  Standard - 1L N. Saline + 2L 5% Dextrose daily 
- No restriction on fluid intake 
- IV fluids to stop day 3 
   
  (for further information refer to the guidelines in the Junior Doctors Room) 
ANALGESIA: 
  Morphine by PCA IV 
 
  Paracetamol 1G qid either PR or PO 
 
NSAIDs allowed after 48hrs 
 
Tramadol 50mg prn 6hrly only after PCA optimised 
  
Patients to have Fortisip drinks twice daily from Day 1. 
 
BOWELS 
 
Time of first flatus ......................... Time of first motion .................... 
 
WEIGHT 
 
 
  ..........     ..........     ..........     ..........     ..........     ..........     ..........     .......... 
  Pre-op       Day 1        Day 2        Day 3        Day 4        Day 5        Day 6        Day 7 
 
HEIGHT 
Please remind patients to fill in their pain and nausea 
scores at 8am and 8pm each day 
  ........... 
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APPEDIX V 
 
FLUID RESTRICTIO STUDY GUIDELIES 
  
We aim to include most patients having major elective abdominal surgery. Patients with 
significant co-morbidity will not be included. Furthermore patients having operations involving 
pelvic dissection will not be included 
 
Patients will have a sheet in their observations folder indicating if they are included in the 
study. 
 
Pre-op:  
 
- Patient’s will have their weight measured. 
  
- They should all be prescribed Clexane 20 mg subcut. at 8pm for DVT 
prophylaxis and wear TED stockings until mobile. 
  
- They can take diet until 6 hours pre-op and clear fluids until 2 hours pre-op. 
 
Bowel preparation: 
  
- Patients for right colon resections do not require bowel prep. 
  
- Patients for left colon resection should have 1 Phosphate enema the evening 
before and 1 Phosphate enema on the day of surgery.  
 
IV Fluids: 
 
Restricted 
  
- 2 L 4% Dextrose/ 0.18% Saline per day. 
  
- Encourage oral fluids from day 1 and stop IV fluids at midnight on day 1. 
  
- Fluid deficit will be judged by urine output (<1.5ml/kg over past 4 hrs) or 
hypotension (<85-90 mmHg systolic) and replaced as colloid. Fluid challenges 
of Gelofusine or blood (depending on Hb) in 250ml boluses at 15min intervals 
until urine output and/or BP improved and CVP normalised 
Remember that the patient can drink so encourage oral fluids 
  
- Remove urinary catheter at midnight on day 1. 
 
Standard 
  
- 1 L . Saline + 2 L 5% Dextrose per day. 
  
- Resucitate as clinically indicated with the fluid of your choice. No restriction to 
fluid regime. Fluids to stop when clinicians feel it is safe after day 3. 
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APPEDIX V (continued) 
Oral intake:  
 
- Encourage oral fluids immediately postoperatively 
 
- Two Fortisip drinks daily until discharge. 
 
- Diet to be introduced as soon as patient will tolerate. 
 
Bloods:  
 
- Patients should have FBC, U+E, Albumin daily including pre-operatively and 
the evening of theatre. 
  
Other blood tests should be taken as clinically indicated. 
 
Analgesia:  
 
- Paracetamol 1g q.i.d. for every patient 
 
- Ibuprofen 600mg orally either as required or regularly only after 48hrs post-op. 
  
If patient gives a history of previous peptic ulcer disease/ dyspeptic symptoms the 
prescribe with Losec 40mg. 
  
If patient gives a history of current ulcer or renal impairment DO OT PRESCRIBE 
 
- PCA Morphine will be used in most cases but this should be stopped by 
midnight of day 2 
  
- Tramadol 100mg prn 6hrly IV/IM for breakthrough pain 
 
 Do not prescribe any other analgesic agents and try to avoid opiate or codeine 
based medication as much as possible. 
 
Monitoring: 
 
A record will be kept of: 
 
 - IV and oral fluid intake 
- Urine output hourly while catheter in-situ 
- Analgesic and antiemetic requirement 
- Blood results daily 
- Height and daily weights 
- Pain and nausea scores twice daily (please remind the patient to fill in 
form) 
 - Time of first flatus and bowel motion 
- Complications 
 
Follow up 
 
Patients will be phoned daily by the research nurse daily for 2 weeks and should be seen at the 
outpatient clinic 1 week after discharge. 
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APPEDIX VII 
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APPEDIX VII (continued) 
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APPEDIX VII (continued) 
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APPEDIX VII (continued) 
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APPEDIX VII (continued) 
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APPEDIX VII (continued) 
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APPEDIX VIII 
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APPEDIX VIII (continued) 
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APPEDIX VIII (continued) 
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